4,281 results on '"R Taylor"'
Search Results
2. Characteristics of Matriculants to Thoracic Surgery Residency Training Programs
- Author
-
Andrew M. Blakely, Mohammad S. Jafferji, Justin Drake, R. Taylor Ripley, Laurence P. Diggs, Sean P. Martin, Jonathan M. Hernandez, Seth M. Steinberg, Michael M. Wach, Jeremy L. Davis, and Chuong D. Hoang
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Matriculation ,American Osteopathic Association ,Population ,Specialty ,Article ,Interquartile range ,Humans ,Medicine ,education ,Schools, Medical ,Retrospective Studies ,Surgeons ,education.field_of_study ,business.industry ,Internship and Residency ,Thoracic Surgery ,Odds ratio ,Thoracic Surgical Procedures ,United States ,Confidence interval ,Education, Medical, Graduate ,Cardiothoracic surgery ,Family medicine ,Female ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Program Evaluation - Abstract
BACKGROUND: Thoracic surgery (TS) residency positions are in high demand. There is no study describing the nationwide attributes of successful matriculants in this specialty. We examined the characteristics of TS resident applicants and identified factors associated with acceptance. METHODS: Applicant data from 2014 to 2017 application cycles was extracted from the Electronic Residency Application System and stratified by matriculation status. Medical education, type of general surgery residency, and research achievements were analyzed. The number of peer-reviewed publications and the corresponding impact factor for the journals where they were published were quantified. RESULTS: There were 492 applicants and 358 matriculants. The overall population was primarily male (79.5%), white (55.1%), educated at United States allopathic medical schools (66.5%), and trained at university-based general surgery residencies (59.6%). Education at United States allopathic schools (odds ratio [OR], 2.54; P< .0001), being a member of the American Osteopathic Association (OR, 3.27; P = .021), general surgery residency affiliation with a TS residency (OR, 2.41; P = .0003) or National Cancer Institute designated Comprehensive Cancer Center (OR, 1.76; P = .0172), and being a first-time applicant (OR, 4.71, P< .0001) were independently associated with matriculation. Matriculants published a higher number of manuscripts than nonmatriculants (median of 3 vs 2, P< .0001) and more frequently published in higher impact journals (P< .0001). CONCLUSIONS: Our study includes objective and quantifiable data from recent application cycles and represents an in-depth examination of applicants to TS residency. The type of medical school and residency, as well as academic productivity, correlate with successful matriculation.
- Published
- 2021
- Full Text
- View/download PDF
3. Pediatric Emergency Medicine Fellowship Procedural Sedation Training
- Author
-
Derya Caglar, Taryn R. Taylor, Rebecca K. Burger, M. Olivia Titus, Morgan J. Sims, Carmen Sulton, Benjamin F. Jackson, Amanda E. Mulcrone, Corrie E. Chumpitazi, Eileen J. Klein, Kim Little-Wienert, Lauren C. Robinson, and Emine M. Tunc
- Subjects
Pediatric emergency medicine ,business.industry ,Sedation ,Pediatrics, Perinatology and Child Health ,Emergency Medicine ,medicine ,General Medicine ,Medical emergency ,medicine.symptom ,business ,medicine.disease - Published
- 2021
- Full Text
- View/download PDF
4. Uterine exteriorization versus in situ repair in Cesarean delivery: a systematic review and meta-analysis
- Author
-
Nadir Sharawi, Cameron R Taylor, Ashraf S. Habib, Hon Sen Tan, Rehena Sultana, and Karen D. Barton
- Subjects
medicine.medical_specialty ,Nausea ,business.industry ,Analgesic ,Exteriorization ,General Medicine ,Odds ratio ,Perioperative ,Anesthesiology and Pain Medicine ,Anesthesia ,Anesthesiology ,medicine ,Vomiting ,medicine.symptom ,business ,Postoperative nausea and vomiting - Abstract
We conducted an updated systematic review and meta-analysis on maternal outcomes associated with uterine exteriorization compared with in situ repair in women undergoing Cesarean delivery. We searched for randomized controlled trials comparing uterine exteriorization with in situ repair during Cesarean delivery. Primary outcomes were intraoperative nausea and vomiting (IONV) and perioperative decrease in hemoglobin concentration. Secondary outcomes were postoperative nausea and vomiting (PONV), estimated blood loss, fever, endometritis, wound infection, intraoperative and postoperative pain, postoperative analgesic use, duration of surgery and hospital stay, and time to return of bowel function. Twenty studies with 20,909 parturients were included. Exteriorization was associated with higher risk of IONV (odds ratio [OR], 2.09; 95% confidence interval [CI], 1.66 to 2.63; I2 = 0%), with no difference in perioperative hemoglobin concentration decrease (mean difference, − 0.06 g·dL-1; 95% CI, − 0.20 to 0.08; I2 = 97%) compared with in situ repair. There were no significant differences in estimated blood loss, transfusion requirement, PONV, duration of surgery, duration of hospital stay, time to return of bowel function, fever, endometritis, or wound infection. Postoperative pain (incidence of pain graded > 5/10) at six hours (OR, 1.64; 95% CI, 1.31 to 2.03; I2 = 0%) was higher with exteriorization, but there was no difference in need for rescue analgesia (OR, 2.48; 95% CI, 0.89 to 6.90; I2 = 94%) or pain scores at 24 hr compared with in situ repair. In this updated systematic review and meta-analysis, uterine exteriorization was associated with an increased risk of IONV but no significant change in perioperative hemoglobin decrease compared with in situ repair. PROSPERO (CRD42020190074); registered 5 July 2020.
- Published
- 2021
- Full Text
- View/download PDF
5. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma
- Author
-
Hyun-Sung Lee, Bryan M. Burt, Alice K. Lee, Hee Jin Jang, Christopher I. Amos, Nihanth Palivela, R. Taylor Ripley, Daniela Ramos, Taylor Splawn, Anjali C. Raghuram, Masatsugu Hamaji, and Maheshwari Ramineni
- Subjects
Mesothelioma ,Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Pleural Neoplasms ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,B7-H1 Antigen ,03 medical and health sciences ,Pneumonectomy ,0302 clinical medicine ,PD-L1 ,Internal medicine ,Biomarkers, Tumor ,medicine ,Humans ,education ,education.field_of_study ,biology ,business.industry ,Hazard ratio ,Perioperative ,Prognosis ,medicine.disease ,Survival Rate ,030228 respiratory system ,Cohort ,biology.protein ,Immunohistochemistry ,Surgery ,Programmed cell death 1 ligand 2 ,Cardiology and Cardiovascular Medicine ,business - Abstract
The prognostic role of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM) is incompletely understood. Our objectives were to evaluate the evidence for tumor PD-L1 as a prognostic biomarker in MPM through meta-analysis and to determine whether tumor PD-L1 expression is associated with survival in MPM patients undergoing macroscopic complete resection.Meta-analysis was performed to determine the association of PD-L1 with overall survival in MPM (n = 1655) from 14 studies containing overall survival and tumor PD-L1 expression. Univariable and multivariable analyses tested the relationship of tumor PD-L1 with overall survival and recurrence-free survival in an institutional cohort of MPM patients treated by macroscopic complete resection (n = 75). To validate the association of PD-L1 with overall survival, we utilized two independent MPM cohorts (n = 284).Meta-analysis demonstrated that high tumor PD-L1 expression was associated with poor overall survival. Among 75 patients undergoing macroscopic complete resection, 49 tumors (65%) expressed PD-L1 (1% or more), and high PD-L1 (50% or greater) was more commonly expressed on nonepithelial (29%) compared with epithelial tumors (14%). High tumor PD-L1 expression was independently associated with poor overall survival (P.001, hazard ratio 5.67) and recurrence-free survival (P = .003, hazard ratio 3.28). The association of PD-L1 overexpression with unfavorable survival was more significant in epithelial MPMs than nonepithelial MPMs. These findings were validated in RNA sequencing analyses in two independent cohorts. Exploratory transcriptome analysis revealed that MPM tumors with PD-L1 overexpression displayed coexpression of other immune regulatory molecules, programmed cell death 1 ligand 2 and T-cell immunoglobulin mucin receptor 3.Tumor PD-L1 expression is a prognostic biomarker in patients undergoing surgical resection for MPM and may be useful in perioperative decision making.
- Published
- 2021
- Full Text
- View/download PDF
6. Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging
- Author
-
Nihanth Palivela, Eugene Choi, Phillip W. Carrott, Bryan M. Burt, Taylor Splawn, R. Taylor Ripley, Lorraine D. Cornwell, George Van Buren, David J. Sugarbaker, and Shawn S. Groth
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,Extrapleural Pneumonectomy ,medicine.medical_specialty ,Pleural Neoplasms ,medicine.medical_treatment ,Radiography ,Diagnostic laparoscopy ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Aged ,Neoplasm Staging ,Retrospective Studies ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Pleural mesothelioma ,Mesothelioma, Malignant ,Magnetic resonance imaging ,Middle Aged ,Decortication ,030228 respiratory system ,Positron emission tomography ,Positron-Emission Tomography ,Female ,Laparoscopy ,Surgery ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Pleurectomy - Abstract
Background With a multimodal treatment strategy, cytoreductive surgery extends survival in malignant pleural mesothelioma. Improving the accuracy of staging can refine patient selection. Our objective was to determine whether diagnostic laparoscopy (DL) improves staging for patients with malignant pleural mesothelioma with the routine use of positron emission tomography (PET). Methods We performed a retrospective review of our prospectively maintained database from February 2014 to May 2019. Inclusion criteria were patients who had disease in the chest that was deemed potentially resectable by radiographic criteria and who underwent DL as part of the staging evaluation before surgery. Results Of 187 patients (71% men, 80% epithelial) who underwent DL during staging, 76% proceeded to surgery; 22% were unresectable at exploratory thoracotomy and 78% underwent resection (pleurectomy and decortication, 68%; extrapleural pneumonectomy, 32%). Also, 89% had a PET computed tomography (CT), and 11% had a preoperative CT without PET. DL revealed peritoneal disease in 17%. Among patients with pathologically proven disease at DL, 77% had negative PET-CT imaging. Based on the pathologic findings at DL the sensitivity, specificity, positive predictive value, and negative predictive value of PET-CT were 23%, 78%, 17%, and 83%, respectively. The accuracy of PET-CT was 68%. Conclusions PET-CT has low sensitivity and diagnostic accuracy to identify peritoneal disease in malignant pleural mesothelioma. DL as part of the preoperative staging defines an important subset of patients with bicavitary disease. We recommend DL as a component of staging before surgery.
- Published
- 2021
- Full Text
- View/download PDF
7. Liquid biopsies in pediatric oncology: opportunities and obstacles
- Author
-
R. Taylor Sundby, Alex Pan, and Jack F. Shern
- Subjects
Adult ,medicine.medical_specialty ,Neoplasm, Residual ,liquid biopsy ,business.industry ,Biopsy ,MEDLINE ,biomarkers ,Adult care ,Disease ,circulating DNA ,Medical Oncology ,Pediatric cancer ,cell-free DNA ,HEMATOLOGY AND ONCOLOGY: Edited by Brigitte Widemann ,Tissue heterogeneity ,Pediatrics, Perinatology and Child Health ,Pediatric oncology ,medicine ,Biomarkers, Tumor ,Humans ,Intensive care medicine ,business ,Child ,Tissue biopsy - Abstract
Purpose of review Liquid biopsies have emerged as a noninvasive alternative to tissue biopsy with potential applications during all stages of pediatric oncology care. The purpose of this review is to provide a survey of pediatric cell-free DNA (cfDNA) studies, illustrate their potential applications in pediatric oncology, and to discuss technological challenges and approaches to overcome these hurdles. Recent findings Recent literature has demonstrated liquid biopsies' ability to inform treatment selection at diagnosis, monitor clonal evolution during treatment, sensitively detect minimum residual disease following local control, and provide sensitive posttherapy surveillance. Advantages include reduced procedural anesthesia, molecular profiling unbiased by tissue heterogeneity, and ability to track clonal evolution. Challenges to wider implementation in pediatric oncology, however, include blood volume restrictions and relatively low mutational burden in childhood cancers. Multiomic approaches address challenges presented by low-mutational burden, and novel bioinformatic analyses allow a single assay to yield increasing amounts of information, reducing blood volume requirements. Summary Liquid biopsies hold tremendous promise in pediatric oncology, enabling noninvasive serial surveillance with adaptive care. Already integrated into adult care, recent advances in technologies and bioinformatics have improved applicability to the pediatric cancer landscape.
- Published
- 2021
8. Interrater Reliability of National Institutes of Health Traumatic Brain Injury Imaging Common Data Elements for Brain Magnetic Resonance Imaging in Mild Traumatic Brain Injury
- Author
-
Xiaoying Sun, Christine L. Mac Donald, Sabrina R Taylor, Esther L. Yuh, Sandra Rincon, Allison Kumar, Daniel M. Krainak, Pratik Mukherjee, Sonia Jain, Amy J. Markowitz, Harvey S. Levin, Nancy R. Temkin, and Geoffrey T. Manley
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Traumatic brain injury ,Diffuse Axonal Injury ,Head trauma ,Young Adult ,Physical medicine and rehabilitation ,Brain Injuries, Traumatic ,medicine ,Humans ,Brain magnetic resonance imaging ,Stroke ,Brain Concussion ,Aged ,Observer Variation ,Common Data Elements ,business.industry ,Reproducibility of Results ,Brain Contusion ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,United States ,Inter-rater reliability ,Female ,Neurology (clinical) ,Artifacts ,business ,Biomarkers - Abstract
The National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH-NINDS) Traumatic Brain Injury (TBI) Imaging Common Data Elements (CDEs) are standardized definitions for pathological intracranial lesions based on their appearance on neuroimaging studies. The NIH-NINDS TBI Imaging CDEs were designed to be as consistent as possible with the U.S. Food and Drug Administration (FDA) definition of biomarkers as "an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention." However, the FDA qualification process for biomarkers requires proof of reliable biomarker test measurements. We determined the interrater reliability of TBI Imaging CDEs on subacute brain magnetic resonance imaging (MRI) performed on 517 mild TBI patients presenting to 11 U.S. level 1 trauma centers. Three U.S. board-certified neuroradiologists independently evaluated brain MRI performed 2 weeks post-injury for the following CDEs: traumatic axonal injury (TAI), diffuse axonal injury (DAI), and brain contusion. We found very high interrater agreement for brain contusion, with prevalence- and bias-adjusted kappa (PABAK) values for pairs of readers from 0.92 [95% confidence interval, 0.88-0.95] to 0.94 [0.90-0.96]. We found intermediate agreement for TAI and DAI, with PABAK values of 0.74-0.78 [0.70-0.82]. The near-perfect agreement for subacute brain contusion is likely attributable to the high conspicuity and distinctive appearance of these lesions on T1-weighted images. Interrater agreement for TAI and DAI was lower, because signal void in small vascular structures, and artifactual foci of signal void, can be difficult to distinguish from the punctate round or linear areas of slight hemorrhage that are a common hallmark of TAI/DAI on MRI.
- Published
- 2021
- Full Text
- View/download PDF
9. The Effect of a 6-Month Exercise Intervention Trial on Allostatic Load in Black Women at Increased Risk for Breast Cancer: the FIERCE Study
- Author
-
Jennifer Hicks, Lucile L. Adams-Campbell, Chiranjeev Dash, Jiachen Lu, and Teletia R. Taylor
- Subjects
medicine.medical_specialty ,Health (social science) ,Sociology and Political Science ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,medicine.disease ,Allostatic load ,law.invention ,Clinical trial ,Impaired glucose tolerance ,Breast cancer ,Randomized controlled trial ,law ,Anthropology ,Internal medicine ,medicine ,Aerobic exercise ,medicine.symptom ,business ,Dyslipidemia ,Abdominal obesity - Abstract
Allostatic load comprises cardiovascular, metabolic, and inflammatory markers, which is characterized by abdominal obesity, high blood glucose levels, impaired glucose tolerance, dyslipidemia, and hypertension and associated with an increased risk in breast cancer. The study was a 6-month, 3-arm randomized controlled trial of two moderate-intensity exercise interventions (compared with a control group) among obese, physically inactive, postmenopausal Black women aged 45 to 65 years, who were at increased risk for breast cancer based on the CARE model. Two hundred thirteen participants were randomly assigned to (1) supervised, facility-based aerobic exercise intervention (n = 73), (2) home-based exercise intervention (n = 69), or (3) a wait-listed control group (n = 71). The intervention effects of exercise on allostatic load were examined with intent-to-treat analyses using generalized linear models. It was revealed that statistically significant decreases in allostatic load over the 6-month period for both exercise intervention groups (i.e., home-based and supervised arms) compared to the controls were observed among the total population, pc-h = 0.023 and pc-s = 0.035, as well as among women with a family history of breast cancer, pc-h = 0.006 and pc-s = 0.012. Short-term aerobic activity improved allostatic load scores in metabolically unhealthy postmenopausal Black women at increased risk for cancer. Clinical trial registration number NCT02103140.
- Published
- 2021
- Full Text
- View/download PDF
10. Does Subthalamic Deep Brain Stimulation Impact Asymmetry and Dyscoordination of Gait in Parkinson’s Disease?
- Author
-
Navrag B. Singh, Christian R. Baumann, William R. Taylor, Niklas König Ignasiak, Lennart Stieglitz, Elena Bernasconi, Mechtild Uhl, Michelle Gwerder, Deepak K. Ravi, and University of Zurich
- Subjects
Male ,gait symmetry ,gait coordination ,Parkinson's disease ,deep brain stimulation ,basal ganglia ,medicine.medical_specialty ,Levodopa ,Deep brain stimulation ,Deep Brain Stimulation ,medicine.medical_treatment ,Stimulation ,610 Medicine & health ,Asymptomatic ,10180 Clinic for Neurosurgery ,Physical medicine and rehabilitation ,Subthalamic Nucleus ,Original Research Articles ,Outcome Assessment, Health Care ,Tremor ,Basal ganglia ,medicine ,Humans ,Postural Balance ,Gait Disorders, Neurologic ,Aged ,business.industry ,Therapeutic effect ,Parkinson Disease ,General Medicine ,Middle Aged ,medicine.disease ,Gait ,Confidence interval ,10040 Clinic for Neurology ,Preferred walking speed ,Parkinson’s disease ,Female ,medicine.symptom ,business ,Psychomotor Performance ,Follow-Up Studies ,medicine.drug - Abstract
Background. Subthalamic deep brain stimulation (STN-DBS) is an effective treatment for selected Parkinson's disease (PD) patients. Gait characteristics are often altered after surgery, but quantitative therapeutic effects are poorly described. Objective. The goal of this study was to systematically investigate modifications in asymmetry and dyscoordination of gait 6 months postoperatively in patients with PD and compare the outcomes with preoperative baseline and to asymptomatic controls without PD. Methods. A convenience sample of thirty-two patients with PD (19 with postural instability and gait disorder (PIGD) type and 13 with tremor dominant disease) and 51 asymptomatic controls participated. Parkinson patients were tested prior to the surgery in both OFF and ON medication states, and 6-months postoperatively in the ON stimulation condition. Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) I to IV and medication were compared to preoperative conditions. Asymmetry ratios, phase coordination index, and walking speed were assessed. Results. MDS-UPDRS I to IV at 6 months improved significantly, and levodopa equivalent daily dosages significantly decreased. STN-DBS increased step time asymmetry (hedges' g effect sizes [95% confidence interval] between pre- and post-surgery: .27 [-.13, .73]) and phase coordination index (.29 [-.08, .67]). These effects were higher in the PIGD subgroup than the tremor dominant (step time asymmetry: .38 [-.06, .90] vs .09 [-.83, 1.0] and phase coordination index: .39 [-.04, .84] vs .13 [-.76, .96]). Conclusions. This study provides objective evidence of how STN-DBS increases asymmetry and dyscoordination of gait in patients with PD and suggests motor subtypes-associated differences in the treatment response., Neurorehabilitation and Neural Repair, 35 (11), ISSN:1545-9683, ISSN:0888-4390, ISSN:1552-6844
- Published
- 2021
- Full Text
- View/download PDF
11. Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett’s esophagus in a multisite case-control study
- Author
-
Ramona Lansing, Douglas W. Mahoney, Kenneth K. Wang, Tsung Teh Wu, Frances K. Cayer, William R. Taylor, Seth W. Slettedahl, Prasad G. Iyer, Lois L. Hemminger, Eduardo Antpack, Hatim T. Allawi, John B. Kisiel, Herbert C. Wolfsen, and Maria Giakoumopoulos
- Subjects
Genetic Markers ,Oncology ,medicine.medical_specialty ,Esophageal Neoplasms ,Cohort Studies ,Barrett Esophagus ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Receiver operating characteristic ,business.industry ,Gastroenterology ,Case-control study ,medicine.disease ,Clinical trial ,ROC Curve ,Genetic marker ,Case-Control Studies ,030220 oncology & carcinogenesis ,Test set ,Barrett's esophagus ,Cohort ,Biomarker (medicine) ,030211 gastroenterology & hepatology ,business - Abstract
Background and Aims We previously identified a 5 methylated DNA marker (MDM) panel for the detection of nonendoscopic Barrett’s esophagus (BE). In this study, we aimed to recalibrate the performance of the 5 MDM panel using a simplified assay in a training cohort, validate the panel in an independent test cohort, and explore the accuracy of an MDM panel with only 3 markers. Methods Participants were recruited from 3 medical centers. The sponge on a string device (EsophaCap; CapNostics, Concord, NC, USA) was swallowed and withdrawn, followed by endoscopy, in BE cases and control subjects. A 5 MDM panel was blindly assayed using a simplified assay. Random forest modeling analysis was performed, in silico cross-validated in the training set, and then locked down, before test set analysis. Results The training set had 199 patients: 110 BE cases and 89 control subjects, and the test set had 89 patients: 60 BE cases and 29 control subjects. Sensitivity of the 5 MDM panel for BE diagnosis was 93% at 90% specificity in the training set and 93% at 93% specificity in the test set. Areas under the receiver operating characteristic curves were .96 and .97 in the training and test sets, respectively. Model accuracy was not influenced by age, sex, or smoking history. Multiple 3 MDM panels achieved similar accuracy. Conclusions A 5 MDM panel for BE is highly accurate in training and test sets in a blinded multisite case-control analysis using a simplified assay. This panel may be reduced to only 3 MDMs in the future. (Clinical trial registration number: NCT 02560623.)
- Published
- 2021
- Full Text
- View/download PDF
12. Interest, Concerns, and Attitudes Among Men Who Have Sex With Men and Health Care Providers Toward Prophylactic Use of Doxycycline Against Chlamydia trachomatis Infections and Syphilis
- Author
-
Justin J Park, Chrysovalantis Stafylis, Jeffrey R. Taylor, Noah Kojima, Daniel D Pearce, Jeffrey D. Klausner, Susan J. Little, and Aleksandr M. Gorin
- Subjects
Male ,Microbiology (medical) ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Health Personnel ,Chlamydia trachomatis ,HIV Infections ,Dermatology ,Drug resistance ,medicine.disease_cause ,Medical and Health Sciences ,Men who have sex with men ,Sexual and Gender Minorities ,Clinical Research ,Behavioral and Social Science ,Health care ,medicine ,Humans ,Syphilis ,Homosexuality, Male ,Doxycycline ,Practice ,business.industry ,Health Knowledge ,Prevention ,Public health ,Public Health, Environmental and Occupational Health ,Homosexuality ,Biological Sciences ,medicine.disease ,Editorial ,Cross-Sectional Studies ,Good Health and Well Being ,Infectious Diseases ,Attitude ,Attitudes ,Family medicine ,Sexually Transmitted Infections ,HIV/AIDS ,Pre-Exposure Prophylaxis ,Public Health ,Willingness to accept ,Infection ,business ,medicine.drug - Abstract
BACKGROUND Prophylactic administration of doxycycline is regarded as a potential new public health strategy to combat the rising rates of Chlamydia trachomatis infections and syphilis among men who have sex with men. We conducted a survey-based study to evaluate how community members and health care providers in Southern California would perceive doxycycline preexposure/postexposure prophylaxis (PrEP/PEP) to predict its acceptability and identify potential areas of concern. METHODS We conducted an online cross-sectional survey among community members who identify as men who have sex with men and health care providers with prescribing authority in Southern California to investigate the current attitudes toward doxycycline PrEP/PEP, including their willingness to accept. We analyzed the data using descriptive statistics and binary logistic regression. RESULTS Among 212 enrolled community member participants, 67.5% indicated they would take doxycycline PrEP/PEP if offered by their provider. Higher acceptability was significantly associated with several characteristics, including recent history of bacterial sexually transmitted infection diagnosis and current use of HIV PrEP. For health care providers, 89.5% of 76 enrolled participants expressed willingness to prescribe doxycycline PrEP/PEP to their patients if recommended by the Centers for Disease Control and Prevention, but only 43.4% were willing if not. Both community members and health care providers demonstrated high levels of concern toward possible drug resistance. CONCLUSIONS Doxycycline PrEP/PEP as a preventive strategy against chlamydial infections and syphilis would likely be accepted among community members and health care providers. Clear guidelines from public health officials and further clarification on the strategy's potential impact on developing drug resistance may be necessary to ensure successful implementation.
- Published
- 2021
- Full Text
- View/download PDF
13. Determination of X-ray detection limit and applications in perovskite X-ray detectors
- Author
-
Wanyi Nie, Neil R. Taylor, L. S. Pan, Lei Cao, and Shreetu Shrestha
- Subjects
Physics ,Photocurrent ,Detection limit ,Multidisciplinary ,business.industry ,Science ,Detector ,X-ray detector ,Imaging and sensing ,General Physics and Astronomy ,General Chemistry ,Article ,Sensors and biosensors ,General Biochemistry, Genetics and Molecular Biology ,Photonic crystals ,Optics ,Optical sensors ,X-rays ,Figure of merit ,Sensitivity (control systems) ,Limit (mathematics) ,business ,Dark current - Abstract
X-ray detection limit and sensitivity are important figure of merits for perovskite X-ray detectors, but literatures lack a valid mathematic expression for determining the lower limit of detection for a perovskite X-ray detector. In this work, we present a thorough analysis and new method for X-ray detection limit determination based on a statistical model that correlates the dark current and the X-ray induced photocurrent with the detection limit. The detection limit can be calculated through the measurement of dark current and sensitivity with an easy-to-follow practice. Alternatively, the detection limit may also be obtained by the measurement of dark current and photocurrent when repeatedly lowering the X-ray dose rate. While the material quality is critical, we show that the device architecture and working mode also have a significant influence on the sensitivity and the detection limit. Our work establishes a fair comparison metrics for material and detector development., The limit of X-ray detection is an important figure of merit for X-ray detectors, yet the suitability of method adopted from Currie’s 1968 paper and the following international standard is in doubt. Here, the authors propose a statistical model that correlates dark current and photo-current, show how it can be used to determine detection limit.
- Published
- 2021
14. The true cost of hidden waiting times for cataract surgery in Australia
- Author
-
Anna Palagyi, Peter McCluskey, Blake Angell, Lisa Keay, Andrew White, Hugh R. Taylor, and Jessie Huang-Lung
- Subjects
Waiting time ,medicine.medical_specialty ,Waiting Lists ,business.industry ,Health Policy ,General surgery ,medicine.medical_treatment ,Public Health, Environmental and Occupational Health ,Australia ,COVID-19 ,Cataract Extraction ,Cataract surgery ,Cataract ,medicine ,Humans ,business - Abstract
Cataract surgery is a safe, effective and common elective procedure in Australia but access is inequitable. True waiting times for cataract care are undisclosed or inconsistently reported by governments. Estimates of true waiting times range from 4 to 30 months and have been extended during the coronavirus disease 2019 (COVID-19) pandemic. Comparative analysis revealed that reducing waiting periods from 12 to 3 months would result in estimated public health system cost savings of $6.6 million by preventing 50 679 falls. Investment in public cataract services to address current unmet needs would prevent avoidable vision impairment and associated negative consequences.
- Published
- 2022
15. Biochemical abnormalities in COVID-19 : a comparison of white versus ethnic minority populations in the UK
- Author
-
Georgios K Dimitriadis, Wiaam Al-Hasani, Jessica Kearney, Tina Mazaheri, David R Taylor, Royce P Vincent, Ruvini N K Ranasinghe, and Devon Buchanan
- Subjects
medicine.medical_specialty ,Minority group ,Ethnic group ,030204 cardiovascular system & hematology ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Intensive care ,medicine ,biochemistry ,030212 general & internal medicine ,Original Research ,White (horse) ,biology ,Troponin T ,business.industry ,Mortality rate ,Public health ,C-reactive protein ,COVID-19 ,General Medicine ,R1 ,inflammation ,biology.protein ,business ,RA ,Demography ,RC - Abstract
AimsPublic Health England has identified that in COVID-19, death rates among ethnic minorities far exceeds that of the white population. While the increase in ethnic minorities is likely to be multifactorial, to date, no studies have looked to see whether values for routine clinical biochemistry parameters differ between ethnic minority and white individuals.MethodsBaseline biochemical data for 22 common tests from 311 SARS-CoV-2 positive patients presenting to hospital in April 2020 in whom ethnicity data were available was retrospectively collected and evaluated. Data comparisons between ethnic minority and white groups were made for all patient data and for the subset of patients subsequently admitted to intensive care.ResultsWhen all patient data were considered, the ethnic minority population had statistically significant higher concentrations of C reactive protein (CRP), aspartate aminotransferase and gamma-glutamyl transferase, while troponin T was higher in the white group. A greater proportion of ethnic minority patients were subsequently admitted to intensive care, but when the presenting biochemistry of this subset of patients was compared, no significant differences were observed between ethnic minority and white groups.ConclusionOur data show for the first time that routine biochemistry at hospital presentation in COVID-19 differs between ethnic minority and white groups. Among the markers identified, CRP was significantly higher in the ethnic minority group pointing towards an increased tendency for severe inflammation in this group.
- Published
- 2022
16. Change in the prevalence of myopia in Australian middle‐aged adults across 20 years
- Author
-
Hugh R. Taylor, Diane Wood, Alex W. Hewitt, Christopher J Hammond, David A. Mackey, Paul Mitchell, Michael Hunter, Seyhan Yazar, Samantha Sze Yee Lee, and Gareth Lingham
- Subjects
Male ,Refractive error ,medicine.medical_specialty ,business.industry ,Visual impairment ,Australia ,Mean age ,Middle Aged ,Refraction, Ocular ,Refractive Errors ,medicine.disease ,European descent ,First world war ,Ophthalmology ,Corneal surgery ,Cohort ,Epidemiology ,Myopia ,Prevalence ,medicine ,Humans ,medicine.symptom ,business ,Aged ,Demography - Abstract
BACKGROUND The prevalence of myopia is increasing globally including in Europe and parts of Asia but Australian data are lacking. This study aim described the change in myopia prevalence in middle-aged Australian adults over approximately a 20-year period. METHODS Two contemporary Western Australian studies (conducted in mid-late 2010s): the coastal-regional Busselton Healthy Ageing Study (BHAS) and the urban Gen1 of the Raine Study (G1RS) were compared to two earlier studies (early-mid 1990s) in Australia: the urban Blue Mountains Eye Study (BMES) and urban/regional Melbourne Visual Impairment Project (MVIP). Refractive error was measured by autorefraction, vertometry, or subjective refraction. Participants (49-70 years) of European descent without self-reported/diagnosed cataract, corneal disease, or refractive or corneal surgery were included. RESULTS After exclusions, data were available from 2217, 1760, 700, 2987 and 756 participants from BMES, urban MVIP, regional MVIP, BHAS, and G1RS, respectively. The mean age ranged from 57.1 ± 4.6 years in the G1RS to 60.1 ± 6.0 years in the BMES; 44-48% of participants were male. When stratified by location, the contemporary urban G1RS cohort had a higher age-standardised myopia prevalence than the urban MVIP and BMES cohorts (29.2%, 16.4%, and 23.9%, p
- Published
- 2021
- Full Text
- View/download PDF
17. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma
- Author
-
John B. Kisiel, Hassan Ghoz, Tracy C. Yab, Xiaoming Cao, Lewis R. Roberts, Gregory J. Gores, Nasra H. Giama, Mohammed M. Aboelsoud, Thomas C. Smyrk, Benjamin R. Kipp, Patrick H. Foote, Calise K. Berger, Ju Dong Yang, William R. Taylor, Douglas W. Mahoney, Emily G. Barr Fritcher, and Catherine D. Moser
- Subjects
Pathology ,medicine.medical_specialty ,Hepatology ,business.industry ,Bisulfite sequencing ,Original Articles ,Methylation ,RC799-869 ,Diseases of the digestive system. Gastroenterology ,medicine.disease ,DNA sequencing ,Primary sclerosing cholangitis ,law.invention ,Differentially methylated regions ,law ,Genetic marker ,DNA methylation ,medicine ,Original Article ,business ,Polymerase chain reaction - Abstract
Cholangiocarcinoma (CCA) has poor prognosis due to late‐stage, symptomatic presentation. Altered DNA methylation markers may improve diagnosis of CCA. Reduced‐representation bisulfite sequencing was performed on DNA extracted from frozen CCA tissues and matched to adjacent benign biliary epithelia or liver parenchyma. Methylated DNA markers (MDMs) identified from sequenced differentially methylated regions were selected for biological validation on DNA from independent formalin‐fixed, paraffin‐embedded CCA tumors and adjacent hepatobiliary control tissues using methylation‐specific polymerase chain reaction. Selected MDMs were then blindly assayed on DNA extracted from independent archival biliary brushing specimens, including 12 perihilar cholangiocarcinoma, 4 distal cholangiocarcinoma cases, and 18 controls. Next, MDMs were blindly assayed on plasma DNA from patients with extrahepatic CCA (eCCA), including 54 perihilar CCA and 5 distal CCA cases and 95 healthy and 22 primary sclerosing cholangitis controls, balanced for age and sex. From more than 3,600 MDMs discovered in frozen tissues, 39 were tested in independent samples. In the clinical pilot of 16 MDMs on cytology brushings, methylated EMX1 (empty spiracles homeobox 1) had an area under the curve (AUC) of 0.98 (95% confidence interval [CI], 0.95‐1.0). In the clinical pilot on plasma, a cross‐validated recursive partitioning tree prediction model from nine MDMs was accurate for de novo eCCA (AUC, 0.88 [0.81‐0.95]) but not for primary sclerosing cholangitis–associated eCCA (AUC, 0.54 [0.35‐0.73]). Conclusion: Next‐generation DNA sequencing yielded highly discriminant methylation markers for CCA. Confirmation of these findings in independent tissues, cytology brushings, and plasma supports further development of DNA methylation to augment diagnosis of CCA., Next‐generation DNA sequencing yielded highly‐discriminant methylation markers for CCA. Confirmation of these findings in independent tissues, cytology brushings, and plasma supports further development of DNA methylation to augment diagnosis of CCA.
- Published
- 2021
18. Central Curation of Glasgow Outcome Scale-Extended Data: Lessons Learned from TRACK-TBI
- Author
-
Sureyya Dikmen, Murray B. Stein, Joan Machamer, Nancy R. Temkin, Joseph T. Giacino, Kim Boase, Yelena G. Bodien, Michael McCrea, Amy J. Markowitz, Sabrina R Taylor, Gabriella Satris, Geoffrey T. Manley, Jason Barber, Lindsay Wilson, and Lindsay D. Nelson
- Subjects
Adult ,Male ,030506 rehabilitation ,medicine.medical_specialty ,Scoring criteria ,Glasgow Outcome Scale ,clinical outcome assessments ,Clinical knowledge ,03 medical and health sciences ,Disability Evaluation ,Young Adult ,0302 clinical medicine ,Documentation ,Brain Injuries, Traumatic ,Outcome Assessment, Health Care ,Medicine ,Humans ,central review ,Longitudinal Studies ,data curation ,Data curation ,business.industry ,traumatic brain injury ,Reproducibility of Results ,Original Articles ,Recovery of Function ,Middle Aged ,United States ,Clinical trial ,GOSE ,Functional Status ,Cohort ,Physical therapy ,Observational study ,Female ,Neurology (clinical) ,0305 other medical science ,business ,030217 neurology & neurosurgery - Abstract
The Glasgow Outcome Scale (GOS) in its original or extended (GOSE) form is the most widely used assessment of global disability in traumatic brain injury (TBI) research. Several publications have reported concerns about assessor scoring inconsistencies, but without documentation of contributing factors. We reviewed 6801 GOSE assessments collected longitudinally, across 18 sites in the 5-year, observational Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. We recorded error rates (i.e., corrections to a section or an overall rating) based on site assessor documentation and categorized scoring issues, which then informed further training. In cohort 1 (n = 1261; February 2014 to May 2016), 24% of GOSEs had errors identified by central review. In cohort 2 (n = 1130; June 2016 to July 2018), acquired after curation of cohort 1 data, feedback, and further training of site assessors, the error rate was reduced to 10%. GOSE sections associated with the most frequent interpretation and scoring difficulties included whether current functioning represented a change from pre-injury (466 corrected ratings in cohort 1; 62 in cohort 2), defining dependency in the home and community (163 corrections in cohort 1; three in cohort 2) and return to work/school (72 corrections in cohort 1; 35 in cohort 2). These results highlight the importance of central review in improving consistency across sites and over time. Establishing clear scoring criteria, coupled with ongoing guidance and feedback to data collectors, is essential to avoid scoring errors and resultant misclassification, which carry potential to result in "failure" of clinical trials that rely on the GOSE as their primary outcome measure.
- Published
- 2021
19. Communities, Co-ops, and Clubs: Social Capital and Incentives in Large Collective Organizations
- Author
-
Aaron Kolb, Joshua A. Jacobs, and Curtis R. Taylor
- Subjects
Transaction cost ,Organizational architecture ,business.industry ,05 social sciences ,Distribution (economics) ,Microeconomics ,Continuation ,Incentive ,Respite care ,Organizational behavior ,Reputation system ,0502 economics and business ,Economic anthropology ,Imperfect ,Business ,050207 economics ,General Economics, Econometrics and Finance ,050205 econometrics ,Social capital - Abstract
We study a continuous-time organization design problem. Each member's output is an imperfect signal of his underlying choice of effort, and each member's utility from remaining in the organization is endogenous to the output of other agents. Monetary transfers are assumed infeasible. Incentives can be provided only through two potential channels: removal due to poor performance (the stick) and rewarding good performance by allowing a "vacation" or respite (the carrot). We derive the steady-state distribution of continuation utilities of agents in the organization and show that both the stick and the carrot are used to provide incentives under an optimal design. Moreover, the optimal organization may be implemented by associating continuation utilities with a reputation system that tracks each member's performance over time.
- Published
- 2021
- Full Text
- View/download PDF
20. Association between serum ferritin, incident primary liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: A nested case–control study
- Author
-
You-Lin Qiao, Zhikai Zhu, Jin-Hu Fan, Philip R. Taylor, Jianfeng Cui, Neal D. Freedman, Wen Chen, Sanford M. Dawsey, Liangyu Yin, Bin Liu, Christian C. Abnet, Jian Yin, and Yuanli Liu
- Subjects
Male ,medicine.medical_specialty ,Hepatitis C virus ,medicine.disease_cause ,Chronic liver disease ,Gastroenterology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Hepatitis B virus ,Clinical Trials as Topic ,Hepatology ,business.industry ,Liver Diseases ,Liver Neoplasms ,Odds ratio ,medicine.disease ,Quartile ,Case-Control Studies ,030220 oncology & carcinogenesis ,Chronic Disease ,Ferritins ,Nested case-control study ,Female ,030211 gastroenterology & hepatology ,Viral hepatitis ,Liver cancer ,business - Abstract
BACKGROUND AND AIM Previous studies suggest that serum ferritin may be associated with higher risk of liver cancer. However, additional studies of the association are needed. It is also not clear whether serum ferritin is associated with mortality from chronic liver disease (CLD). METHODS We performed a nested case-control study in the Linxian Nutrition Intervention Trials. Baseline serum ferritin was measured for 226 incident primary liver cancer cases, 281 CLD mortalities diagnosed, and 1061 age-matched, gender-matched, and trial-matched controls. We used multivariable logistic regression models to calculate odds ratios and 95% confidence intervals. Subgroup analysis and interaction tests were performed by age, gender, alcohol drinking, hepatitis B virus seropositivity (HBV+)/hepatitis C virus seropositivity (HCV+), and trial. RESULTS Participants with serum ferritin in the highest quartile, as compared with those in the lowest quartile, had an increased risk of CLD mortality (odds ratio = 1.72, 95% confidence interval = 1.12, 2.64, P-trend
- Published
- 2021
- Full Text
- View/download PDF
21. Core curriculum for endoscopic submucosal dissection (ESD)
- Author
-
Mihir S. Wagh, Aparna Repaka, Kathryn R. Byrne, Renee Williams, Theodore W. James, Hiroyuki Aihara, Gobind S. Anand, Jason R. Taylor, Prabhleen Chahal, Thomas E. Kowalski, Sunil A Sheth, Mohammed Saadi, and Sunil Dacha
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,Gastroenterology ,MEDLINE ,medicine ,Radiology, Nuclear Medicine and imaging ,Endoscopic submucosal dissection ,business ,Core curriculum - Published
- 2021
- Full Text
- View/download PDF
22. Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study
- Author
-
Benjamin Tingey, Belinda R Taylor, Simon J. Fisher, Benjamin Haaland, Kim Svoboda, Andreana N. Holowatyj, Cornelia M. Ulrich, Mia Hashibe, J Ryan Butcher, Vikrant Deshmukh, William A. Dunson, Richard Viskochil, David W. Wetter, Dominik Ose, Dalton Wilson, Mikaela Larson, and Jennifer Leiser
- Subjects
medicine.medical_specialty ,Huntsman Cancer Institute ,medicine.medical_treatment ,030209 endocrinology & metabolism ,Article ,Cohort Studies ,Prediabetic State ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,Pancreatic cancer ,Diabetes mellitus ,Internal medicine ,Diabetes Mellitus ,Prevalence ,medicine ,Humans ,Prediabetes ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,Radiation therapy ,Oncology ,030220 oncology & carcinogenesis ,Cohort ,Female ,business ,Cohort study - Abstract
BACKGROUND: This study aimed to understand the prevalence of prediabetes and diabetes in patients with cancer overall, by tumor site, by cancer treatment, and by time point in the cancer continuum. METHODS: This cohort study has been conducted at the Huntsman Cancer Institute, Salt Lake City, Utah. Patients with a first primary invasive cancer enrolled in the Total Cancer Care protocol between July 2016 and July 2018 were eligible for this analysis. The prevalence of prediabetes and diabetes is based on ICD code, laboratory tests for HbA1c (%), fasting plasma glucose (mg/dl), non-fasting blood glucose (mg/dl), or insulin prescription. RESULTS: The final cohort comprised 3,512 patients with cancer, with a mean age of 57.8 years at cancer diagnosis. Of all patients, 49.1% (n=1,724) were female. At cancer diagnosis, the prevalence of prediabetes was 6.0% (95% CI: 5.3–6.8) and of diabetes 12.2% (95% CI: 11.2–13.3). One year after diagnosis the prevalences were 16.6% for prediabetes (95% CI: 15.4–17.9) and 25.0% for diabetes (95% CI: 23.6–26.4). At the end of the observation period, the prevalence of prediabetes was 21.2% (95% CI: 20.4–23.0) and of diabetes was 32.6% (95% CI: 29.2–32.1). Patients with myeloma (39.2%; 95% CI: 32.6–46.2) had the highest prevalence of prediabetes and patients with pancreatic cancer the highest prevalence of diabetes (65.1%; 95% CI: 57.0–72.3). In patients who underwent chemotherapy (prediabetes: 29.1% vs 15.6%; diabetes: 37.6% vs 29.0%), radiation therapy (prediabetes: 24.3% vs. 19.9%; diabetes: 33.7% vs 32.1%), or immunotherapy (diabetes: 29.2% vs 20.4; prediabetes: 36.0% vs 32.2%), the prevalence of prediabetes and diabetes was higher compared to patients not undergoing those therapies. CONCLUSIONS: Every second patient with cancer suffers from prediabetes or diabetes. It is essential to foster interprofessional collaboration and to develop evidence-based practice guidelines. A better understanding of the impact of cancer treatment on the development of prediabetes and diabetes remains critical.
- Published
- 2021
- Full Text
- View/download PDF
23. Core curriculum for ergonomics in endoscopy
- Author
-
Catharine M. Walsh, Hiroyuki Aihara, Mihir S. Wagh, Mohammed Saadi, Emad Qayed, Aparna Repaka, Prabhleen Chahal, Sunil A Sheth, Theodore W. James, Jason R. Taylor, Thomas E. Kowalski, Gobind S. Anand, Renee Williams, Sunil Dacha, and Kathryn R. Byrne
- Subjects
Medical education ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,MEDLINE ,Medicine ,Human factors and ergonomics ,Radiology, Nuclear Medicine and imaging ,business ,Core curriculum ,Endoscopy - Published
- 2021
- Full Text
- View/download PDF
24. A Feasibility Study of Smoking Cessation Utilizing an Exercise Intervention among Black Women: ‘Quit and Fit’
- Author
-
Lucile L. Adams-Campbell, Cassandra A. Stanton, Carla Williams, Teletia R. Taylor, Jennifer Hicks, and Kepher H. Makambi
- Subjects
medicine.medical_specialty ,media_common.quotation_subject ,medicine.medical_treatment ,Quit smoking ,Article ,Nicotine ,Intervention (counseling) ,medicine ,Humans ,media_common ,Black women ,Exercise intervention ,business.industry ,Smoking ,General Medicine ,Abstinence ,Retention rate ,Exercise Therapy ,Black or African American ,Physical therapy ,Feasibility Studies ,Smoking cessation ,Female ,Smoking Cessation ,business ,medicine.drug - Abstract
Background Women who engage in higher levels of exercise while trying to quit smoking have been shown to be less likely to relapse and to sustain their smoking abstinence longer. This study sought to examine the benefits of exercise for improving smoking cessation among Black women. Methods We evaluated the feasibility of a 12-week smoking and exercise intervention, Quit and Fit, tailored for Black women. All participants (intervention and control) received 12 weeks of smoking cessation counseling via telephone and 9 weeks of nicotine lozenges. Participants who were randomly assigned to the intervention condition were also assigned to a 12-week exercise group. Results Thirty-eight women were enrolled and 27 completed a 12-week follow-up assessment. Women from the intervention group were more likely to complete the 12-week follow-up assessment compared to participants in the control group (80% vs. 61%). Overall, 7 of the 38 participants (18%) were abstinent at 12 weeks (biochemically verified by expired carbon monoxide). Among the 25 women who completed the 12-week follow-up, abstinence was reported in 33% of the intervention group and 20% of the control group. Using an intent-to-treat approach, 25% of women in the intervention group were abstinent at 12 weeks (n = 5), compared to 11.1% for the control group (n = 2). These differences were not statistically significant. Conclusions The overall retention rate was 71% (27/38) at 12 weeks with higher among the intervention group (16/20; 80%) compared to the control group (11/18; 61%). The study demonstrates that it is feasible to retain African-American women in a short-term study of smoking cessation and exercise.
- Published
- 2021
- Full Text
- View/download PDF
25. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
- Author
-
Camilo Jimenez, Henricus P. M. Kunst, Eric Baudin, Nicola Tufton, Philippe Herman, Rodney J. Hicks, Simon Aylwin, Mercedes Robledo, Henri J L M Timmers, Anne Paule Gimenez-Roqueplo, William F. Young, Massimo Mannelli, Roderick J. Clifton-Bligh, Patricia L. M. Dahia, Mitsuhide Naruse, Alexandre Buffet, Andrzej Januszewicz, Olivier Steichen, Scott Akker, Charlotte Lussey-Lepoutre, Karel Pacak, Martin Fassnacht, David R Taylor, Laurence Amar, Ashley B. Grossman, Giorgio Treglia, Jacques W.M. Lenders, Dylan Lewis, Nelly Burnichon, David Taïeb, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Service de Médecine Interne [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), St Bartholomew's Hospital, King's College Hospital (KCH), Institut Gustave Roussy (IGR), Médecine nucléaire, Département d'imagerie médicale [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Royal North Shore Hospital (RNSH), The University of Sydney, The University of Texas at San Antonio (UTSA), University of Würzburg, Churchill Hospital, Churchill Hospital Oxford Centre for Haematology, Royal Free Hospital [London, UK], Barts & The London School of Medicine and Dentistry, Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Melbourne, Institute of Cardiology (WARSAW - Cardiology), Institute of Cardiology, The University of Texas M.D. Anderson Cancer Center [Houston], Radboud University Medical Center [Nijmegen], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Kyoto Medical Center, National Hospital Organization, Spanish National Cancer Research Center (CNIO), Centro de Investigación Biomédica en Red de Enfermedades Raras - CIBERER [Santiago de Compostela, Spain] (Grupo de Medicina Xenómica), Universidade de Santiago de Compostela [Spain] (USC ), Hôpital de la Timone [CHU - APHM] (TIMONE), Ente Ospedaliero Cantonale (EOC), Lausanne University Hospital, Università della Svizzera italiana = University of Italian Switzerland (USI), Mayo Clinic, Technische Universität Dresden = Dresden University of Technology (TU Dresden), Service de médecine nucléaire [CHU Pitié-Salpétrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, KNO, and MUMC+: MA Keel Neus Oorheelkunde (9)
- Subjects
0301 basic medicine ,PHEOCHROMOCYTOMA ,Pediatrics ,Internationality ,SDHB ,Endocrinology, Diabetes and Metabolism ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,0302 clinical medicine ,Endocrinology ,Mass Screening ,CAROTID-BODY TUMORS ,Child ,HIGH-ALTITUDE ,Molecular medicine ,medicine.diagnostic_test ,Genetic Carrier Screening ,GASTROINTESTINAL STROMAL TUMORS ,Vascular damage Radboud Institute for Molecular Life Sciences [Radboudumc 16] ,[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism ,Penetrance ,3. Good health ,Succinate Dehydrogenase ,PARAGANGLIOMA ,030220 oncology & carcinogenesis ,Mutation (genetic algorithm) ,Algorithms ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] ,Adult ,Heterozygote ,PENETRANCE ,medicine.medical_specialty ,Consensus ,Genetic counseling ,Adrenal tumours ,03 medical and health sciences ,Germline mutation ,medicine ,Humans ,Genetic Testing ,Germ-Line Mutation ,Mass screening ,Aged ,Monitoring, Physiologic ,Genetic testing ,business.industry ,CLINICAL UTILITY ,GENE ,METANEPHRINES ,030104 developmental biology ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,Asymptomatic Diseases ,MATERNAL TRANSMISSION ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,SDHD ,business - Abstract
Approximately 20% of patients diagnosed with a phaeochromocytoma or paraganglioma carry a germline mutation in one of the succinate dehydrogenase (SDHx) genes (SDHA, SDHB, SDHC and SDHD), which encode the four subunits of the SDH enzyme. When a pathogenic SDHx mutation is identified in an affected patient, genetic counselling is proposed for first-degree relatives. Optimal initial evaluation and follow-up of people who are asymptomatic but might carry SDHx mutations have not yet been agreed. Thus, we established an international consensus algorithm of clinical, biochemical and imaging screening at diagnosis and during surveillance for both adults and children. An international panel of 29 experts from 12 countries was assembled, and the Delphi method was used to reach a consensus on 41 statements. This Consensus Statement covers a range of topics, including age of first genetic testing, appropriate biochemical and imaging tests for initial tumour screening and follow-up, screening for rare SDHx-related tumours and management of elderly people who have an SDHx mutation. This Consensus Statement focuses on the management of asymptomatic SDHx mutation carriers and provides clinicians with much-needed guidance. The standardization of practice will enable prospective studies in the near future.
- Published
- 2021
- Full Text
- View/download PDF
26. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities
- Author
-
Thamarangsi Thanksphon, Brijesh Takkar, Hugh R. Taylor, Rajiv Khandekar, Sobha Sivaprasad, Patanjali Dev Nayar, Padmaja Kumari Rani, Taraprasad Das, Peter Wiedemann, and János Németh
- Subjects
medicine.medical_specialty ,Referral ,Fundus Oculi ,MEDLINE ,Review Article ,03 medical and health sciences ,0302 clinical medicine ,Artificial Intelligence ,Political science ,Diabetes Mellitus ,Photography ,medicine ,Global health ,Humans ,Mass Screening ,Human resources ,Mass screening ,Diabetic Retinopathy ,medicine.diagnostic_test ,business.industry ,Public health ,Fundus photography ,Guideline ,Ophthalmology ,Family medicine ,030221 ophthalmology & optometry ,business ,030217 neurology & neurosurgery - Abstract
Diabetic retinopathy (DR) is a global health burden. Screening for sight-threatening DR (STDR) is the first cost-effective step to decrease this burden. We analyzed the similarities and variations between the recent country-specific and the International Council of Ophthalmology (ICO) DR guideline to identify gaps and suggest possible solutions for future universal screening. We selected six representative national DR guidelines, one from each World Health Organization region, including Canada (North America), England (Europe), India (South- East Asia), Kenya (Africa), New Zealand (Western Pacific), and American Academy of Ophthalmology Preferred Practice Pattern (used in Latin America and East Mediterranean). We weighed the newer camera and artificial intelligence (AI) technology against the traditional screening methodologies. All guidelines agree that screening for DR and STDR in people with diabetes is currently led by an ophthalmologist; few engage non-ophthalmologists. Significant variations exist in the screening location and referral timelines. Screening with digital fundus photography has largely replaced traditional slit-lamp examination and ophthalmoscopy. The use of mydriatic digital 2-or 4-field fundus photography is the current norm; there is increasing interest in using non-mydriatic fundus cameras. The use of automated DR grading and tele-screening is currently sparse. Country-specific guidelines are necessary to align with national priorities and human resources. International guidelines such as the ICO DR guidelines remain useful in countries where no guidelines exist. Validation studies on AI and tele-screening call for urgent policy decisions to integrate DR screening into universal health coverage to reduce this global public health burden.摘要: 糖尿病视网膜病变(DR)是全球性的健康负担。筛查威胁视力的DR (STDR)是降低这一负担的第一个具有成本效益的步骤。我们分析了不同国家特有的指南和国际眼科理事会(ICO)指南之间的共同点和差异点, 以确定差距, 并为未来的普遍筛查提出可能的解决方案。我们选择了六个具有代表性国家的DR指南, 每个世界卫生组织区域各一个, 包括加拿大 (北美) 、英国 (欧洲) 、印度 (东南亚) 、肯尼亚 (非洲) 、新西兰 (西太平洋) 和美国眼科学会首选的临床模式 (拉丁美洲和东地中海) 。我们考量了较新的照相技术、人工智能 (AI) 技术与传统筛查方法之间的差别。所有指南都认为糖尿病患者的DR和STDR筛查应该由眼科医生主导进行, 仅少量主张非眼科医生参与。但筛选地点和转诊时间不同指南之间存在显著差异。数字眼底照相筛检在很大程度上取代了传统的裂隙灯检查和检眼镜。散瞳后的数字眼底照相视野2个或4个视野范围是目前的标准, 但免散瞳的眼底照相也逐渐兴起。目前很少使用自动进行DR分级和远程筛查。根据各国的重点政策和人力资源情况制定相应的具体指南必不可少。但国际指南如ICO-DR指南在没有具体指南的国家仍然可以使用。为了减轻这一全球公共卫生负担, 有关AI和远程筛查的有效性研究需要立刻进行政策决策, 以将DR筛查纳入全民健康的覆盖范围。.
- Published
- 2021
- Full Text
- View/download PDF
27. ABO genotypes and the risk of esophageal and gastric cancers
- Author
-
Yingxi Chen, Philip R. Taylor, Christian C. Abnet, Kai Yu, Jian-Min Yuan, Alisa M. Goldstein, You-Lin Qiao, Linda M. Liao, Wei Zheng, Woon-Puay Koh, Nan Hu, Sanford M. Dawsey, Xiao-Ou Shu, Jin-Hu Fan, and Neal D. Freedman
- Subjects
Male ,China ,Cancer Research ,medicine.medical_specialty ,Esophageal Neoplasms ,Genotyping Techniques ,Single-nucleotide polymorphism ,Adenocarcinoma ,Polymorphism, Single Nucleotide ,Risk Assessment ,Gastroenterology ,ABO Blood-Group System ,Asian People ,Stomach Neoplasms ,Esophageal squamous cell carcinoma ,Internal medicine ,ABO blood group system ,Genotype ,Genetics ,Humans ,Medicine ,ABO blood type ,Allele ,RC254-282 ,Blood type ,business.industry ,Cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Middle Aged ,Gastric Cardia Adenocarcinoma ,medicine.disease ,digestive system diseases ,Oncology ,Case-Control Studies ,Female ,business ,Gastric cancer ,Research Article - Abstract
Background Blood type has been associated with the risk of gastric cancer, but few studies have examined the association with esophageal squamous cell carcinoma (ESCC). Methods We conducted a case-control study using genotyping data of Chinese individuals, including cases of 2022 ESCC, 1189 gastric cardia adenocarcinoma, 1161 gastric noncardia adenocarcinoma, and 2696 controls. Genetic blood type was imputed using three single nucleotide polymorphisms. We used logistic regression to examine the association between blood type and the risk of each cancer. Results Compared to blood type O, the risk of ESCC was significantly elevated for blood type B and AB, with the highest risk for type AB (OR, 95%CI: 1.34, 1.07–1.67). Analysis of genotype suggested that the association of ESCC was from carrying the B allele. Similarly, blood type was significantly associated with gastric noncardia adenocarcinoma (P P = 0.13). Conclusions This study provides novel insights into the association between blood type and the risk of ESCC and restricted previously observed association to only gastric noncardia cancer, providing important evidence to clarify the pattern of association and suggesting mechanisms of action.
- Published
- 2021
28. Quantification of morning stiffness to assess disease activity and treatment effects in rheumatoid arthritis
- Author
-
Robert Biesen, Lorenzo Pelli, Jeremias Hollnagel, Sandra Herrmann, Heide Boeth, Frank Buttgereit, William R. Taylor, Rainald Ehrig, and Georg N. Duda
- Subjects
Adult ,medicine.medical_specialty ,Evening ,Pilot Projects ,Prom ,Severity of Illness Index ,Arthritis, Rheumatoid ,Rheumatology ,Internal medicine ,Outcome Assessment, Health Care ,medicine ,Humans ,Pharmacology (medical) ,Aged ,Morning ,Arthrometry, Articular ,Passive resistance ,business.industry ,Metacarpophalangeal joint ,Middle Aged ,medicine.disease ,medicine.anatomical_structure ,Antirheumatic Agents ,Case-Control Studies ,Joint stiffness ,Rheumatoid arthritis ,Female ,medicine.symptom ,Range of motion ,business - Abstract
Objectives The clinical parameter of morning stiffness is widely used to assess the status of RA, but its accurate quantitative assessment in a clinical setting has not yet been successful. This lack of individual quantification limits both personalized medication and efficacy evaluation in the treatment of RA. Methods We developed a novel technology to assess passive resistance of the MCP III joint (stiffness) and its passive range of motion (PRoM). Within this pilot study, 19 female postmenopausal RA patients and 9 healthy controls were examined in the evening as well as the morning of the following day. To verify the specificity of the biomechanical quantification, 11 patients with RA were assessed both prior to and ∼3 h after glucocorticoid therapy. Results While the healthy controls showed only minor changes between afternoon and morning, in RA patients the mean PRoM decreased significantly by 18% (s.d. 22) and stiffness increased significantly by 20% (s.d. 18) in the morning compared with the previous afternoon. We found a significant positive correlation between RA activity and biomechanical measures. Glucocorticoids significantly increased the mean PRoM by 16% (s.d. 11) and reduced the mean stiffness by 23% (s.d. 22). Conclusion This technology allowed mechanical stiffness to be quantified in MCP joints and demonstrated high sensitivity with respect to disease status as well as medication effect in RA patients. Such non-invasive, low-risk and rapid assessment of biomechanical joint stiffness opens a novel avenue for judging therapy efficacy in patients with RA and potentially also in other non-RA inflammatory joint diseases.
- Published
- 2021
- Full Text
- View/download PDF
29. Serum Levels of Androgens, Estrogens, and Sex Hormone Binding Globulin and Risk of Primary Gastric Cancer in Chinese Men: A Nested Case–Control Study
- Author
-
Jiansong Ren, Yuanli Liu, Christian C. Abnet, Zhikai Zhu, You-Lin Qiao, Yingxi Chen, Jin-Hu Fan, Neal D. Freedman, Philip R. Taylor, Jian Yin, and Sanford M. Dawsey
- Subjects
Adult ,Male ,0301 basic medicine ,China ,Cancer Research ,Physiology ,Logistic regression ,Risk Assessment ,Article ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Sex hormone-binding globulin ,Risk Factors ,Stomach Neoplasms ,Sex Hormone-Binding Globulin ,Biomarkers, Tumor ,medicine ,Humans ,Aged ,biology ,business.industry ,Cancer ,Estrogens ,Odds ratio ,Middle Aged ,medicine.disease ,030104 developmental biology ,Oncology ,Quartile ,Case-Control Studies ,030220 oncology & carcinogenesis ,Nested case-control study ,Androgens ,biology.protein ,Female ,business ,Body mass index ,Hormone - Abstract
Gastric cancer shows a strong male predominance, and sex steroid hormones have been hypothesized to explain this sex disparity. Previous studies examining the associations between sex hormones and sex hormone binding globulin (SHBG) and risk of gastric cancer come primarily from western populations and additional studies in diverse populations will help us better understand the association. We performed a nested case–control study in Linxian Nutrition Intervention Trials cohorts to evaluate the associations among Chinese men, where we had sufficient cases to perform a well-powered study. Using radioimmunoassays and immunoassays, we quantitated androgens, estrogens, and SHBG in baseline serum from 328 men that developed noncardia gastric cancer and matched controls. We used multivariable unconditional logistic regression to calculate ORs and 95% confidence intervals (CI) and explored interactions with body mass index (BMI), age, alcohol drinking, smoking, and follow-up time. Subjects with SHBG in the highest quartile, as compared with those in the lowest quartile, had a significantly increased risk of gastric cancer (OR = 1.87; 95% CI, 1.01–3.44). We found some evidence for associations of sex steroid hormones in men with lower BMI. Our study found a novel association suggesting that higher serum concentrations of SHBG may be associated with risk of gastric cancer in men. We found no overall associations with sex hormones themselves, but future studies should expand the scope of these studies to include women and further explore whether BMI modifies a potential association. Prevention Relevance: It was the first study to investigate the association of gastric cancer with prediagnostic sex steroid hormones and SHBG in an Asian male population. Although there were no overall associations for sex steroid hormone concentrations, higher concentrations of SHBG was associated with increased risk of noncardia gastric cancer.
- Published
- 2021
- Full Text
- View/download PDF
30. A Human Dectin-2 Deficiency Associated With Invasive Aspergillosis
- Author
-
Keith Wilson, Pierre J. Rizkallah, Magdalena A. Czubala, Aiysha Thompson, Rosemary Ann Barnes, Mark Gurney, James S Griffiths, P. Lewis White, Selinda J. Orr, Elena Simonazzi, Frank L. van de Veerdonk, Wendy Ingram, Philip R. Taylor, Mariolina Bruno, Diogo M da Fonseca, and Julian R. Naglik
- Subjects
0301 basic medicine ,Antifungal Agents ,CLR ,medicine.medical_treatment ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Aspergillosis ,medicine.disease_cause ,Aspergillus fumigatus ,Fatal Outcome ,0302 clinical medicine ,Immunology and Allergy ,innate immunity ,Sequence Deletion ,Candida ,Mutation ,biology ,Innate Immunity ,Stop codon ,AcademicSubjects/MED00290 ,Aspergillus ,Infectious Diseases ,Cytokine ,Host-Pathogen Interactions ,Dectin-2 ,fungal immunology ,host–pathogen interactions ,Fungal Immunology ,Frameshift mutation ,Immunocompromised Host ,Major Articles and Brief Reports ,03 medical and health sciences ,All institutes and research themes of the Radboud University Medical Center ,SDG 3 - Good Health and Well-being ,medicine ,Humans ,Lectins, C-Type ,AcademicSubjects/MED00860 ,Interleukin 6 ,Inflammation ,business.industry ,Fungi ,030208 emergency & critical care medicine ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,inflammation ,Immunology ,biology.protein ,business ,Invasive Fungal Infections - Abstract
Immunocompromised patients are highly susceptible to invasive aspergillosis. Herein, we identified a homozygous deletion mutation (507 del C) resulting in a frameshift (N170I) and early stop codon in the fungal binding Dectin-2 receptor, in an immunocompromised patient. The mutated form of Dectin-2 was weakly expressed, did not form clusters at/near the cell surface and was functionally defective. Peripheral blood mononuclear cells from this patient were unable to mount a cytokine (tumor necrosis factor, interleukin 6) response to Aspergillus fumigatus, and this first identified Dectin-2–deficient patient died of complications of invasive aspergillosis., We identified a Dectin-2 N170I mutation in an immunocompromised patient who died of complications of invasive aspergillosis. This mutation results in an early stop codon and poor receptor expression and renders Dectin-2 functionally defective.
- Published
- 2021
- Full Text
- View/download PDF
31. Animal protein intake reduces risk of functional impairment and strength loss in older adults
- Author
-
R. Taylor Pickering, M. Loring Bradlee, Martha R. Singer, Mengjie Yuan, Lynn L. Moore, and Jabed Mustafa
- Subjects
Male ,0301 basic medicine ,Sarcopenia ,medicine.medical_specialty ,Offspring ,Frail Elderly ,030209 endocrinology & metabolism ,Muscle Strength Dynamometer ,Critical Care and Intensive Care Medicine ,Lower risk ,Diet Surveys ,Plant Proteins, Dietary ,Diet Records ,03 medical and health sciences ,Grip strength ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Animal Proteins, Dietary ,Epidemiology ,medicine ,Humans ,Exercise ,Geriatric Assessment ,Aged ,Aged, 80 and over ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Framingham Risk Score ,Frailty ,Hand Strength ,business.industry ,Middle Aged ,medicine.disease ,Diet ,Functional Status ,Plant protein ,Female ,business - Abstract
Protein intake has been shown to lower risk of aging-related functional decline. The goal of this study was to assess long-term effects of weight-adjusted animal (AP) and plant protein (PP) intakes on aging-related change in functional status and grip strength.Framingham Offspring Study participants (n = 1896, 891 men and 1005 women), ≥age 50, were followed for an average of 14.4 years. Protein intake derived from two sets of 3-day diet records (exams 3 and 5) was expressed as both weight-adjusted intake (from residuals) and per kilogram of body weight (g/kg/d). Seven tasks from two standardized assessments (Nagi and the Rosow-Breslau scales) were selected to determine functional status at exams 5-9. Functional impairment was defined as failure to complete (or having a lot of difficulty completing) a given task. Grip strength was assessed by dynamometer at exams 7-9.Participants with higher (vs. lower) weight-adjusted intakes of AP and PP maintained higher functional scores (p = 0.001 and p 0.001, respectively). After accounting for baseline skeletal muscle mass (SMM) and physical activity, only AP was linked with lower risks of functional impairment. Higher AP intake among sedentary individuals led to 29% (95% CI: 0.51-1.00) reduced risks of impairment; among subjects with lower SMM, higher AP was associated with 30% (95% CI: 0.49-0.98) reduced risks. Physical activity and SMM were independently associated with reduced risks of functional impairment, regardless of protein intake. Finally, higher AP intake led to 34% and 48% greater preservation of grip strength in men (p = 0.012) and women (p = 0.034). Results were similar for protein intake expressed as g/kg/d.Higher AP intake and higher levels of physical activity and SMM were independently associated with lower risks of functional impairment and greater preservation of grip strength in adults over the age of 50 years.
- Published
- 2021
- Full Text
- View/download PDF
32. Assessment of Orthopedic Versus Neurologic Causes of Gait Change in Dogs and Cats
- Author
-
Sharon C. Kerwin and Amanda R. Taylor
- Subjects
medicine.medical_specialty ,040301 veterinary sciences ,Lameness, Animal ,Cat Diseases ,Culprit ,0403 veterinary science ,Dogs ,Physical medicine and rehabilitation ,Forelimb ,Animals ,Medicine ,Dog Diseases ,Small Animals ,Neurologic Examination ,Proprioception ,business.industry ,0402 animal and dairy science ,Hyperesthesia ,04 agricultural and veterinary sciences ,040201 dairy & animal science ,Gait ,Orthopedics ,medicine.anatomical_structure ,Lameness ,Orthopedic surgery ,Cats ,Reflex ,medicine.symptom ,business - Abstract
Diagnosis of forelimb lameness may be challenging, as it not only can be due to multiple common orthopedic diseases but also may occasionally be caused by neurologic disease. A thorough orthopedic and neurologic examination is key to determining which disease category is the likely culprit. Deficits identified on the neurologic examination, such as proprioceptive deficits, changes in reflexes, and presence of spinal hyperesthesia, are key in identifying neurologic causes of forelimb lameness.
- Published
- 2021
- Full Text
- View/download PDF
33. Prospectively Assigned AAST Grade versus Modified Hinchey Class and Acute Diverticulitis Outcomes
- Author
-
Ryan Seltzer, David A. Spain, Zelin Li, Harsh Wadhwa, Jeff Choi, Kovi Bessoff, Rebecca Bromley-Dulfano, Lisa M. Knowlton, Anshal Gupta, and Kathryn R. Taylor
- Subjects
Adult ,Male ,medicine.medical_specialty ,Support Vector Machine ,Clinical Decision-Making ,Length of hospitalization ,Risk Assessment ,Severity of Illness Index ,Decision Support Techniques ,law.invention ,Young Adult ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,law ,Electronic Health Records ,Humans ,Medicine ,Prospective Studies ,Diverticulitis ,Societies, Medical ,Aged ,Aged, 80 and over ,Acute diverticulitis ,business.industry ,Incidence ,General surgery ,Incidence (epidemiology) ,Electronic medical record ,Small sample ,Middle Aged ,Intensive care unit ,Class (biology) ,United States ,Traumatology ,030220 oncology & carcinogenesis ,Feasibility Studies ,Female ,030211 gastroenterology & hepatology ,Surgery ,business - Abstract
The American Association for the Surgery of Trauma (AAST) recently developed a classification system to standardize outcomes analyses for several emergency general surgery conditions. To highlight this system's full potential, we conducted a study integrating prospective AAST grade assignment within the electronic medical record.Our institution integrated AAST grade assignment into our clinical workflow in July 2018. Patients with acute diverticulitis were prospectively assigned AAST grades and modified Hinchey classes at the time of surgical consultation. Support vector machine-a machine learning algorithm attuned for small sample sizes-was used to compare the associations between the two classification systems and decision to operate and incidence of complications.67 patients were included (median age of 62 y, 40% male) for analysis. The decision for operative management, hospital length of stay, intensive care unit admission, and intensive care unit length of stay were associated with both increasing AAST grade and increasing modified Hinchey class (all P 0.001). AAST grade additionally showed a correlation with complication severity (P = 0.02). Compared with modified Hinchey class, AAST grade better predicted decision to operate (88.2% versus 82.4%).This study showed the feasibility of electronic medical record integration to support the full potential of AAST classification system's utility as a clinical decision-making tool. Prospectively assigned AAST grade may be an accurate and pragmatic method to find associations with outcomes, yet validation requires further study.
- Published
- 2021
- Full Text
- View/download PDF
34. Long-term follow-up after multilevel surgery in cerebral palsy
- Author
-
William R. Taylor, Reinald Brunner, Nadine Hasler, Rosa M. S. Visscher, Erich Rutz, Navrag B. Singh, and Marie Freslier
- Subjects
Pelvic tilt ,030222 orthopedics ,medicine.medical_specialty ,Long term follow up ,business.industry ,Multilevel surgery ,030229 sport sciences ,General Medicine ,medicine.disease ,Statistical parametric mapping ,Gait ,Cerebral palsy ,03 medical and health sciences ,0302 clinical medicine ,Physical medicine and rehabilitation ,Bilateral spastic cerebral palsy ,Orthopedic surgery ,medicine ,Orthopedics and Sports Medicine ,Surgery ,business ,human activities - Abstract
Single-event multilevel surgery (SEMLS) is frequently used to correct pathological gait patterns in children with bilateral spastic cerebral palsy (BSCP) in a single session surgery. However, in-depth long-term evaluation reports of gait outcomes are limited. Therefore, we investigated if SEMLS is able to correct lower extremity joint and pelvic angles during gait towards typically developing gait patterns (TDC) in children with BSCP, and if so, if this effect is durable over a 10-year period. In total 13 children with BSCP GMFCS level II at time of index-surgery between the ages of 7.7–18.2 years at the time of SEMLS were retrospectively recruited. Three-dimensional gait data were captured preoperatively, as well as at short-, mid-, and long-term post-operatively, and used to analyze: movement analysis profile (MAP), gait profile score (GPS), and lower extremity joint and pelvic angles over the course of a gait cycle using statistical parametric mapping. In agreement with previous studies, MAP and GPS improved towards TDCs after surgery, as did knee extension during the stance phase (ɳ2 = 0.67; p
- Published
- 2021
- Full Text
- View/download PDF
35. High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
- Author
-
John B. Kisiel, William R. Taylor, Calise K. Berger, Kelli N. Burger, Gloria M. Petersen, David A. Ahlquist, Chung Wah Wu, Douglas W. Mahoney, Graham P. Lidgard, Karen A. Doering, Hatim T. Allawi, Neil Postier, Jaime de la Fuente, Patrick H. Foote, Suresh T. Chari, Shounak Majumder, and William R. Bamlet
- Subjects
Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,CA-19-9 Antigen ,endocrine system diseases ,Comorbidity ,Article ,03 medical and health sciences ,0302 clinical medicine ,Text mining ,Pancreatic cancer ,Internal medicine ,Biomarkers, Tumor ,medicine ,Humans ,Neoplasm Staging ,Receiver operating characteristic ,business.industry ,Computational Biology ,DNA Methylation ,medicine.disease ,Confidence interval ,Pancreatic Neoplasms ,ROC Curve ,Genetic marker ,Case-Control Studies ,030220 oncology & carcinogenesis ,Biomarker (medicine) ,Female ,030211 gastroenterology & hepatology ,CA19-9 ,Detection rate ,business - Abstract
Purpose:We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case–control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC.Experimental Design:Thirteen MDMs (GRIN2D, CD1D, ZNF781, FER1L4, RYR2, CLEC11A, AK055957, LRRC4, GH05J042948, HOXA1, PRKCB, SHISA9, and NTRK3) were identified on the basis of selection criteria applied to results of prior tissue experiments and assays were optimized in plasma. Next, 340 plasma samples (170 PDAC cases and 170 controls) were assayed using target enrichment long-probe quantitative amplified signal method. Initially, 120 advanced-stage PDAC cases and 120 healthy controls were used to train a prediction algorithm at 97.5% specificity using random forest modeling. Subsequently, the locked algorithm derived from the training set was applied to an independent blinded test set of 50 early-stage PDAC cases and 50 controls. Finally, data from all 340 patients were combined, and cross-validated.Results:The cross-validated area under the receiver operating characteristic curve (AUC) for the training set was 0.93 (0.89–0.96) for the MDM panel alone, 0.91 (95% confidence interval, 0.87–0.96) for carbohydrate antigen 19-9 (CA19-9) alone, and 0.99 (0.98–1) for the combined MDM-CA19-9 panel. In the test set of early-stage PDAC, the AUC for MDMs alone was 0.84 (0.76–0.92), CA19-9 alone was 0.87 (0.79–0.94), and combined MDM-CA19-9 panel was 0.90 (0.84–0.97) significantly better compared with either MDMs alone or CA19-9 alone (P = 0.0382 and 0.0490, respectively). At a preset specificity of 97.5%, the sensitivity for the combined panel in the test set was 80% (28%–99%) for stage I disease and 82% (68%–92%) for stage II disease. Using the combined datasets, the cross-validated AUC was 0.9 (0.86–0.94) for the MDM panel alone and 0.89 for CA19-9 alone (0.84–0.93) versus 0.97 (0.94–0.99) for the combined MDM-CA19-9 panel (P ≤ 0.0001). Overall, cross-validated sensitivity of MDM-CA19-9 panel was 92% (83%–98%), with an observed specificity of 92% at the preset specificity of 97.5%.Conclusions:Plasma MDMs in combination with CA19-9 detect PDAC with significantly higher accuracy compared with either biomarker individually.
- Published
- 2021
- Full Text
- View/download PDF
36. Colonoscopy core curriculum
- Author
-
C. Roberto Simons-Linares, Mihir S. Wagh, Christopher S. Huang, Sarah B. Umar, Lisa Cassani, Thomas E. Kowalski, Hiroyuki Aihara, Vladimir Kushnir, Emad Qayed, Gobind S. Anand, Sahar Ghassemi, Jason R. Taylor, Catharine M. Walsh, Stacie A F Vela, Renee Williams, Prabhleen Chahal, Sunil A Sheth, Sunil Dacha, and Anna Duloy
- Subjects
Medical education ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,MEDLINE ,Medicine ,Colonoscopy ,Radiology, Nuclear Medicine and imaging ,business ,Core curriculum - Published
- 2021
- Full Text
- View/download PDF
37. Core curriculum for endoscopic mucosal resection
- Author
-
Sahar Ghassemi, Lisa Cassani, Mihir S. Wagh, Gobind S. Anand, Sarah B. Umar, Vladimir Kushnir, Christopher S. Huang, Stacie A F Vela, Sunil Dacha, Anna Duloy, Prabhleen Chahal, Sunil A Sheth, Renee Williams, Hiroyuki Aihara, C. Roberto Simons-Linares, Emad Qayed, Catharine M. Walsh, Jason R. Taylor, and Thomas E. Kowalski
- Subjects
medicine.medical_specialty ,Text mining ,business.industry ,General surgery ,Gastroenterology ,MEDLINE ,medicine ,Radiology, Nuclear Medicine and imaging ,Endoscopic mucosal resection ,business ,Core curriculum - Published
- 2021
- Full Text
- View/download PDF
38. Core curriculum for endoscopic ablative techniques
- Author
-
C. Roberto Simons-Linares, Mihir S. Wagh, Christopher S. Huang, Catharine M. Walsh, Gobind S. Anand, Sahar Ghassemi, Emad Qayed, Sarah B. Umar, Renee Williams, Vladimir Kushnir, Stacie A F Vela, Prabhleen Chahal, Sunil A Sheth, Sunil Dacha, Anna Duloy, Hiroyuki Aihara, Lisa Cassani, Jason R. Taylor, and Thomas E. Kowalski
- Subjects
medicine.medical_specialty ,Radiofrequency ablation ,business.industry ,Gastroenterology ,MEDLINE ,Argon plasma coagulation ,Core curriculum ,law.invention ,law ,Ablative case ,medicine ,Radiology, Nuclear Medicine and imaging ,Medical physics ,business - Published
- 2021
- Full Text
- View/download PDF
39. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research
- Author
-
John A. Sauceda, Lynda Dee, Jeffrey R. Taylor, Parya Saberi, Jeremy Sugarman, Danielle Campbell, Mallory O. Johnson, Brandon Brown, Michael J. Peluso, John Kanazawa, and Karine Dubé
- Subjects
medicine.medical_specialty ,business.industry ,Sexually Transmitted Diseases ,Human immunodeficiency virus (HIV) ,virus diseases ,HIV Infections ,medicine.disease_cause ,Research Personnel ,Article ,Sexual Partners ,Infectious Diseases ,Family medicine ,Related research ,Humans ,Medicine ,Pharmacology (medical) ,Viremia ,business ,Risk management - Abstract
BACKGROUND: Analytical treatment interruptions (ATIs) in HIV cure-related research can result in trial participants becoming viremic with HIV, placing HIV-negative sexual partners at elevated risk of acquiring HIV. OBJECTIVE: Our study aimed to generate ethical and practical considerations for designing and implementing appropriate risk mitigation strategies to reduce unintended HIV transmission events during ATIs. METHODS: We conducted 21 in-depth interviews with five types of informants: bioethicists, community members, biomedical HIV cure researchers, socio-behavioral scientists/epidemiologists, and HIV care providers. We used conventional content analysis to analyze the data and generate considerations. RESULTS: Key findings include: 1) Ethical permissibility of ATI trials depends on due diligence and informed consent to mitigate risks to participants and their sexual partners; 2) Participants should receive adequate support and/or counseling if they choose to disclose ATI participation to their partners; 3) Measures to protect sexual partners of trial participants from HIV transmission during ATIs should include referral to and/or provision of pre-exposure prophylaxis, as well as other available means of preventing HIV transmission; 4) There is uncertainty regarding the appropriate management of emerging sexually transmitted infections during ATI trials and possible protection measures for multiple and/or anonymous partners of ATI trial participants. CONCLUSION: While there is no way to completely eliminate the risk of HIV transmission to sexual partners during ATIs, HIV cure trialists and sponsors should consider the ethical concerns related to the sexual partners of ATI participants. Doing so is essential to ensuring the welfare of participants, their partners and the trustworthiness of research.
- Published
- 2021
- Full Text
- View/download PDF
40. Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence
- Author
-
Kelli N. Burger, Douglas W. Mahoney, Graham P. Lidgard, Xiaoming Cao, Hao Xie, Tsung Teh Wu, Patrick H. Foote, Karen A. Doering, William R. Taylor, Hatim T. Allawi, Michael W. Kaiser, Joleen M. Hubbard, Calise K. Berger, David A. Ahlquist, Sara S. Then, John B. Kisiel, and Maria McGlinch
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Colorectal cancer ,Concordance ,Disease ,Target enrichment ,Article ,03 medical and health sciences ,0302 clinical medicine ,Carcinoembryonic antigen ,Internal medicine ,Biomarkers, Tumor ,medicine ,Humans ,Watchful Waiting ,neoplasms ,Aged ,Plasma samples ,biology ,business.industry ,Area under the curve ,Reproducibility of Results ,DNA Methylation ,Middle Aged ,medicine.disease ,digestive system diseases ,030104 developmental biology ,ROC Curve ,Genetic marker ,Case-Control Studies ,030220 oncology & carcinogenesis ,biology.protein ,Feasibility Studies ,Female ,Neoplasm Recurrence, Local ,Colorectal Neoplasms ,business - Abstract
Purpose: We aimed to assess the concordance of colorectal cancer–associated methylated DNA markers (MDM) in primary and metastatic colorectal cancer for feasibility in detection of distantly recurrent/metastatic colorectal cancer in plasma. Experimental Design: A panel of previously discovered colorectal cancer–associated MDMs was selected. MDMs from primary and paired metastatic colorectal cancer tissue were assayed with quantitative methylation-specific PCR. Plasma MDMs were measured blindly by target enrichment long-probe quantitative-amplified signal assays. Random forest modeling was used to derive a prediction algorithm of MDMs in archival plasma samples from primary colorectal cancer cases. This algorithm was validated in prospectively collected plasma samples from recurrent colorectal cancer cases. The accuracy of the algorithm was summarized as sensitivity, specificity, and area under the curve (AUC). Results: Of the 14 selected MDMs, the concordance between primary and metastatic tissue was considered moderate or higher for 12 MDMs (86%). At a preset specificity of 95% (91%–98%), a panel of 13 MDMs, in plasma from 97 colorectal cancer cases and 200 controls, detected stage IV colorectal cancer with 100% (80%–100%) sensitivity and all stages of colorectal cancer with an AUC of 0.91 (0.87–0.95), significantly higher than carcinoembryonic antigen [AUC, 0.72 (0.65–0.79)]. This panel, in plasma from 40 cases and 60 healthy controls, detected recurrent/metastatic colorectal cancer with 90% (76%–97%) sensitivity, 90% (79%–96%) specificity, and an AUC of 0.96 (0.92–1.00). The panel was positive in 0.30 (0.19–0.43) of 60 patients with no evidence of disease in post-operative patients with colorectal cancer. Conclusions: Plasma assay of novel colorectal cancer–associated MDMs can reliably detect both primary colorectal cancer and distantly recurrent colorectal cancer with promising accuracy.
- Published
- 2021
- Full Text
- View/download PDF
41. A review of natural disturbances to inform implementation of ecological forestry in Nova Scotia, Canada
- Author
-
Mark Pulsifer, Peter D. Neily, David A. MacLean, Bruce Stewart, Sean P. Basquill, Derek Gilby, Eugene Quigley, Anthony R. Taylor, and Celia K. Boone
- Subjects
0106 biological sciences ,Nova scotia ,Geography ,010504 meteorology & atmospheric sciences ,business.industry ,Environmental resource management ,business ,010603 evolutionary biology ,01 natural sciences ,Natural (archaeology) ,0105 earth and related environmental sciences ,General Environmental Science - Abstract
Like many jurisdictions across North America, the province of Nova Scotia (NS) is faced with the challenge of restoring its forests to a more natural, presettlement state through implementation of ecological forestry. At the core of ecological forestry is the idea that natural forest structures and processes may be approximated by designing management practices that emulate natural disturbances. Successful natural disturbance emulation depends on fundamental knowledge of disturbance characteristics, including identification of specific disturbance agents, their spatial extent, severity, and return interval. To date, no comprehensive synthesis of existing data has been undertaken to document the natural disturbance regime of NS forests, limiting the application of natural disturbance emulation. Using over 300 years of documents and available data, we identified the main natural disturbance agents that affect NS forests and characterized their regimes. Overall, fire, wind (predominantly hurricanes), and outbreaks of spruce budworm (Choristoneura fumiferana (Clemens)) are the most important disturbance agents, causing substantial areas of low- (60%) severity disturbance. While characterization of natural historic fire is challenging, due to past human ignitions and suppression, we estimated that the mean annual disturbance rate of moderate- to high-severity fire ranged between 0.17% and 0.4%·year−1 (return interval of 250–600 years), depending on ecosystem type. Hurricanes make landfall in NS, on average, every 7 years, resulting in wide-scale (>500 ha) forest damage. While hurricane track and damage severity vary widely among storms, the return interval of low- to high-severity damage is 700–1250 years (0.14%–0.08%·year−1). Conversely, the return interval of host-specific spruce budworm outbreaks is much shorter (
- Published
- 2020
- Full Text
- View/download PDF
42. The sustainability of the New Zealand radiation therapy workforce: Factors that influence intent to leave the workplace and profession
- Author
-
Michael R. Taylor and John G. Oetzel
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,Population ageing ,Pride ,media_common.quotation_subject ,lcsh:R895-920 ,lcsh:RC254-282 ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Health care ,Radiology, Nuclear Medicine and imaging ,Advanced practice ,Workplace ,Care Planning ,media_common ,Response rate (survey) ,Medical education ,ComputingMilieux_THECOMPUTINGPROFESSION ,Oncology (nursing) ,business.industry ,Health Policy ,Flexibility (personality) ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,ComputingMilieux_GENERAL ,Radiation therapy ,Career development ,Sustainability ,030220 oncology & carcinogenesis ,Workforce ,business ,Psychology ,Research Article - Abstract
Highlights • The New Zealand radiation therapist (RT) workforce is in a vulnerable state. • 33% of RTs are thinking of leaving their current workplace. • 35% of RTs intend to change careers before they retire. • Being challenged and limited career development pathways influence RT retention. • Strategies need to focus on advanced practice opportunities that challenge RTs., Introduction The demand for radiation therapy services in New Zealand is growing due to an increasing and ageing population. The radiation therapist (RT) workforce is currently in a vulnerable state and this study aimed to understand RT perceptions on intent to remain in both the workplace and profession. Understanding factors that contribute to satisfaction and retention are important for the development of strategies by healthcare leaders to improve workforce sustainability. Materials and methods All current practising RTs were invited via email link to complete an online survey. Multivariate regression models were used to investigate any impact of demographic, workplace and professional variables on intent to remain in the workplace and intent to leave the profession. Results Three hundred and sixty two (91% response rate) RTs completed the survey. Key findings include: a) 33% are thinking of leaving their current workplace with 31% of these intending to leave within the next 12 months; b) 35% intend to change careers before they retire; and c) 25% indicated they would leave the profession if they could. Workplace satisfaction, being challenged and a lack of career development opportunities were common factors that influence intention to leave both the workplace and profession. Conclusions Strategies to ensure the sustainability of the RT workforce in New Zealand need to focus on developing a robust framework for career development including advanced practice opportunities that challenge RTs and ensuring workplaces create an environment that promote a sense of pride, camaraderie and flexibility in how they operate.
- Published
- 2020
43. Psychological distress and trauma during the COVID-19 pandemic: survey of doctors practising anaesthesia, intensive care medicine, and emergency medicine in the United Kingdom and Republic of Ireland
- Author
-
Tom Roberts, Robert Hirst, Camilla Sammut-Powell, Charles Reynard, Jo Daniels, Daniel Horner, Mark D. Lyttle, Katie Samuel, Blair Graham, Michael J. Barrett, James Foley, John Cronin, Etimbuk Umana, Joao Vinagre, Edward Carlton, L. Kane, L. Mackenzie, S. Sharma Hajela, J. Phizacklea, K. Malik, N. Mathai, A. Sattout, S. Messahel, E. Fadden, R. McQuillan, B. O'Hare, S. Lewis, D. Bewick, R. Taylor, I. Hancock, D. Manthalapo Ramesh Babu, S. Hartshorn, M. Williams, A. Charlton, L. Somerset, C. Munday, A. Turner, R. Sainsbury, E. Williams, S. Patil, R. Stewart, M. Winstanley, N. Tambe, C. Magee, D. Raffo, D. Mawhinney, B. Taylor, T. Hussan, G. Pells, F. Barham, F. Wood, C. Szekeres, R. Greenhalgh, S. Marimuthu, R. Macfarlane, M. Alex, B. Shrestha, L. Stanley, J. Gumley, K. Thomas, M. Anderson, C. Weegenaar, J. Lockwood, T. Mohamed, S. Ramraj, M. Mackenzie, A. Robertson, W. Niven, M. Patel, S. Subramaniam, C. Holmes, S. Bongale, U. Bait, S. Nagendran, S. Rao, F. Mendes, P. Singh, T. Baron, C. Ponmani, M. Depante, R. Sneep, A. Brookes, S. Williams, A. Rainey, J. Brown, N. Marriage, S. Manou, S. Hart, M. Elsheikh, L. Cocker, M.H. Elwan, K.L. Vincent, C. Nunn, N. Sarja, M. Viegas, E. Wooffinden, C. Reynard, N. Cherian, A. Da-Costa, S. Duckitt, J. Bailey, L. How, T. Hine, F. Ihsan, H. Abdullah, K. Bader, S. Pradhan, M. Manoharan, L. Kehler, R. Muswell, M. Bonsano, J. Evans, E. Christmas, K. Knight, L. O'Rourke, K. Adeboye, K. Iftikhar, R. Evans, R. Darke, R. Freeman, E. Grocholski, K. Kaur, H. Cooper, M. Mohammad, L. Harwood, K. Lines, C. Thomas, D. Ranasinghe, S. Hall, J. Wright, N. Ali, J. Hunt, H. Ahmad, C. Ward, M. Khan, K. Holzman, J. Ritchie, A. Hormis, R. Hannah, A. Corfield, J. Maney, D. Metcalfe, S. Timmis, C. Williams, R. Newport, D. Bawden, A. Tabner, H. Malik, C. Roe, D. McConnell, F. Taylor, R. Ellis, S. Morgan, L. Barnicott, S. Foster, J. Browning, L. McCrae, E. Godden, A. Saunders, A. Lawrence-Ball, R. House, J. Muller, I. Skene, M. Lim, H. Millar, A. Rai, K. Challen, S. Currie, M. Elkanzi, T. Perry, W. Kan, L. Brown, M. Cheema, A. Clarey, A. Gulati, K. Webster, A. Howson, R. Doonan, A. Trimble, C. O’Connell, R. Wright, E. Colley, C. Rimmer, S. Pintus, H. Jarman, V. Worsnop, S. Collins, M. Colmar, N. Masood, R. McLatchie, A. Peasley, S. Rahman, N. Mullen, L. Armstrong, A. Hay, R. Mills, J. Lowe, H. Raybould, A. Ali, P. Cuthbert, S. Taylor, V. Talwar, Z. Al-Janabi, C. Leech, J. Turner, L. McKechnie, B. Mallon, J. McLaren, Y. Moulds, L. Dunlop, F.M. Burton, S. Keers, L. Robertson, D. Craver, N. Moultrie, O. Williams, S. Purvis, M. Clark, C. Davies, S. Foreman, C. Ngua, J. Morgan, N. Hoskins, J. Fryer, L. Frost, P. Ellis, A. Mackay, K. Gray, M. Jacobs, I. Musliam Veettil Asif, P. Amiri, S. Shrivastava, F. Raza, S. Wilson, M. Riyat, H. Knott, M. Ramazany, S. Langston, N. Abela, L. Robinson, D. Maasdorp, H. Murphy, H. Edmundson, R. Das, C. Orjioke, D. Worley, W. Collier, J. Everson, N. Maleki, A. Stafford, S. Gokani, M. Charalambos, A. Olajide, C. Bi, J. Ng, S. Naeem, A. Hill, C. Boulind, R. O'Sullivan, S. Gilmartin, S. Uí Bhroin, P. Fitzpatrick, A. Patton, M. Jee Poh Hock, S. Graham, S. Kukaswadia, C. Prendergast, A. Ahmed, C. Dalla Vecchia, J. Lynch, M. Grummell, I. Grossi, B. MacManus, P. Turton, C. Battle, K. Samuel, A. Boyle, A. Waite, D. George, B. Johnston, J. Anandarajah, and J. Vinagre
- Subjects
Adult ,Male ,medicine.medical_specialty ,Critical Care ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Psychological Distress ,Cohort Studies ,Stress Disorders, Post-Traumatic ,SDG 3 - Good Health and Well-being ,emergency medicine ,Physicians ,Surveys and Questionnaires ,Intensive care ,Pandemic ,medicine ,Humans ,Anesthesia ,Longitudinal Studies ,Prospective Studies ,Pandemics ,intensive care ,business.industry ,COVID-19 ,Psychological distress ,anaesthesia ,medicine.disease ,Mental health ,United Kingdom ,Anesthesiology and Pain Medicine ,Family medicine ,Emergency Medicine ,Female ,business ,psychological trauma ,Ireland ,mental health ,Cohort study ,Psychological trauma - Abstract
Received 12th May 2021. Accepted 17th May 2021. Published online 28th May 2021. Issue published 1st August 2021.
- Published
- 2021
- Full Text
- View/download PDF
44. Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma
- Author
-
R. Taylor Ripley
- Subjects
Pulmonary and Respiratory Medicine ,Extrapleural Pneumonectomy ,medicine.medical_specialty ,Lung ,Performance status ,business.industry ,Pleural Neoplasms ,medicine.medical_treatment ,Mesothelioma, Malignant ,Perioperative ,Thoracic Surgical Procedures ,Decortication ,medicine.disease ,medicine.disease_cause ,Asbestos ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,medicine ,Humans ,Pleura ,Mesothelioma ,business ,Pleurectomy - Abstract
Extended pleurectomy and decortication (ePD) is a difficult operation performed for the surgical resection of malignant pleural mesothelioma that can achieve a macroscopic complete resection with preservation of the lung. With lower perioperative mortality, similar long-term survival, and better tolerance in patients with lower performance status, ePD has become the preferred operation rather than extrapleural pneumonectomy despite lack of a direct comparison. As ePD has become more popular, international collaboration is underway to create surgical guidelines based on collection of operative data. These efforts will improve the safety and standardization of this operation.
- Published
- 2020
- Full Text
- View/download PDF
45. Tonic-clonic seizure after unrecognized unintentional dural puncture
- Author
-
Jennifer E. Mehdiratta, Cameron R Taylor, Ashraf S. Habib, Jennifer E. Dominguez, and Mary Yurashevich
- Subjects
Epidural blood patch ,Post-dural-puncture headache ,business.industry ,Clonic seizure ,Obstetrics and Gynecology ,Intensive care unit ,Complete resolution ,nervous system diseases ,law.invention ,Tonic (physiology) ,body regions ,Anesthesiology and Pain Medicine ,law ,Anesthesia ,otorhinolaryngologic diseases ,Medicine ,medicine.symptom ,business ,Intracranial Hypotension ,Hospital stay - Abstract
Patients who suffer an unintentional dural puncture have a high risk of developing a post-dural puncture headache. Other neurologic complications have been reported, but seizure is rarely seen. We present a case of a 21-year-old primigravida who experienced an unrecognized unintentional dural puncture that ultimately resulted in a tonic-clonic seizure from intracranial hypotension one week following the dural breach. Her trachea was intubated and she was transferred to the intensive care unit. Two epidural blood patches, performed by neuroradiologists, were needed before the patient experienced complete resolution of her headache. During the re-admission, she also experienced a pulmonary embolus which further lengthened her hospital stay.
- Published
- 2020
- Full Text
- View/download PDF
46. Dysregulation of Decision Making Related to Metabotropic Glutamate 5, but Not Midbrain D3, Receptor Availability Following Cocaine Self-administration in Rats
- Author
-
Heather Liu, Daeyeol Lee, Evan D. Morris, Ansel T. Hillmer, Stephanie M. Groman, Daniel Holden, Krista Fowles, and Jane R. Taylor
- Subjects
0301 basic medicine ,business.industry ,media_common.quotation_subject ,Addiction ,Glutamate receptor ,Abstinence ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Metabotropic receptor ,Dopamine receptor ,Dopamine receptor D3 ,Dopamine receptor D2 ,Medicine ,Self-administration ,business ,Neuroscience ,030217 neurology & neurosurgery ,Biological Psychiatry ,media_common - Abstract
Background Compulsive patterns of drug use are thought to be the consequence of drug-induced adaptations in the neural mechanisms that enable behavior to be flexible. Neuroimaging studies have found evidence of robust alterations in glutamate and dopamine receptors within brain regions that are known to be critical for decision-making processes in cocaine-dependent individuals, and these changes have been argued to be the consequence of persistent drug use. The causal relationships among drug-induced alterations, cocaine taking, and maladaptive decision-making processes, however, are difficult to establish in humans. Methods We assessed decision making in adult male rats using a probabilistic reversal learning task and used positron emission tomography with the [11C]-(+)-PHNO and [18F]FPEB radioligands to quantify regional dopamine D2/3 and metabotropic glutamate 5 (mGlu5) receptor availability, respectively, before and after 21 days of cocaine or saline self-administration. Tests of motivation and relapse-like behaviors were also conducted. Results We found that self-administration of cocaine, but not of saline, disrupted behavior in the probabilistic reversal learning task measured by selective impairments in negative-outcome updating and also increased cortical mGlu5 receptor availability following 2 weeks of forced abstinence. D2/3 and, importantly, midbrain D3 receptor availability was not altered following 2 weeks of abstinence from cocaine. Notably, the degree of the cocaine-induced increase in cortical mGlu5 receptor availability was related to the degree of disruption in negative-outcome updating. Conclusions These findings suggest that cocaine-induced changes in mGlu5 signaling may be a mechanism by which disruptions in negative-outcome updating emerge in cocaine-dependent individuals.
- Published
- 2020
- Full Text
- View/download PDF
47. Midbrain D3 Receptor Availability Predicts Escalation in Cocaine Self-administration
- Author
-
Ansel T. Hillmer, Daniel Holden, Jane R. Taylor, Daeyeol Lee, Evan D. Morris, Krista Fowles, Heather Liu, and Stephanie M. Groman
- Subjects
0301 basic medicine ,business.industry ,Metabotropic glutamate receptor 5 ,Addiction ,media_common.quotation_subject ,Extinction (psychology) ,Biomarker (cell) ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Neuroimaging ,Dopamine receptor D3 ,Dopamine receptor D2 ,Medicine ,Self-administration ,business ,Neuroscience ,030217 neurology & neurosurgery ,Biological Psychiatry ,media_common - Abstract
Background Results from neuroimaging studies suggest that disruptions in flexible decision-making functions in substance-dependent individuals are a consequence of drug-induced neural adaptations. In addicted populations, however, the causal relationship between biobehavioral phenotypes of susceptibility and addiction consequence is difficult to dissociate. Indeed, evidence from animals suggests that poor decision making due to preexisting biological factors can independently enhance the risk for developing addiction-like behaviors. Neuroimaging studies in animals provide a unique translational approach for the identification of the neurobiological mechanisms that mediate susceptibility to addiction. Methods We used positron emission tomography in rats to quantify regional dopamine D2/3 receptors and metabotropic glutamate receptor 5 (mGluR5) and assessed decision making using a probabilistic reversal learning task. Susceptibility to self-administer cocaine was then quantified for 21 days followed by tests of motivation and relapse-like behaviors. Results We found that deficits specifically in reward-guided choice behavior on the probabilistic reversal learning task predicted greater escalation of cocaine self-administration behavior and greater motivation for cocaine and, critically, were associated with higher midbrain D3 receptor availability. Additionally, individual differences in midbrain D3 receptor availability independently predicted the rate of escalation in cocaine-taking behaviors. No differences in mGluR5 availability, responses during tests of extinction, or cue-induced reinstatement were observed between the groups. Conclusions These findings indicate that our identified D3-mediated decision-making phenotype can be used as a behavioral biomarker for assessment of cocaine use susceptibility in human populations.
- Published
- 2020
- Full Text
- View/download PDF
48. A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)
- Author
-
Gini F. Fleming, Heshan Liu, Jeff A. Sloan, Charles L. Loprinzi, Michelle J. Naughton, Jane M. Armer, Jill M. Oliveri, Gary Unzeitig, Marianne Melnik, Lisa D. Yee, Karen Hock, John R. Taylor, Drew K. Seisler, Electra D. Paskett, Michael Schwartz, and Jennifer Le-Rademacher
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Breast Neoplasms ,Article ,law.invention ,Poor adherence ,Young Adult ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Breast cancer ,Randomized controlled trial ,law ,Early Medical Intervention ,Humans ,Medicine ,Cooperative group ,Lymphedema ,030212 general & internal medicine ,Range of Motion, Articular ,Mastectomy ,Aged ,Aged, 80 and over ,business.industry ,Incidence ,Incidence (epidemiology) ,Middle Aged ,Hand ,medicine.disease ,humanities ,Exercise Therapy ,body regions ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Arm ,Physical therapy ,Lymph Node Excision ,Female ,Self Report ,business ,Range of motion ,Healthcare providers ,Follow-Up Studies - Abstract
Background Lymphedema affects many women who are treated for breast cancer. We examined the effectiveness of an education-only (EO) versus education plus sleeve compression/exercise intervention (lymphedema education and prevention [LEAP]) on lymphedema incidence and range of motion (ROM) in a group-randomized trial across 38 cooperative group sites. Methods The treating institution was randomly assigned to either EO or LEAP by a study statistician. All patients at a treating institution participated in the same intervention (EO or LEAP) to minimize contamination bias. Participants completed surveys, arm volume measurements, and self-reported ROM assessments before surgery and at 12 and 18 months after surgery. Lymphedema was defined as a ≥10% difference in limb volume at any time post-surgery up to 18 months after surgery or diagnosis by a health provider. Cochran-Mantel-Haenszel tests were used to compare lymphedema-free rates between groups, stratified by lymph node surgery type. Self-reported ROM differences were compared between groups. Results A total of 554 participants (56% LEAP) were included in the analyses. At 18 months, lymphedema-free rates were 58% (EO) versus 55% (LEAP) (P = .37). ROM for both arms was greater in LEAP versus EO at 12 months; by 18 months, most women reported full ROM, regardless of group. In LEAP, only one-third wore a sleeve ≥75% of the time; 50% performed lymphedema exercises at least weekly. Conclusion Lymphedema incidence did not differ by intervention group at 18 months. Poor adherence in the LEAP group may have contributed. However, physical therapy may speed recovery of ROM. Further research is needed to effectively reduce the incidence and severity of lymphedema in patients who have breast cancer.
- Published
- 2020
- Full Text
- View/download PDF
49. Techniques for In Vivo Measurement of Ligament and Tendon Strain: A Review
- Author
-
Naomi C. Adam, William R. Taylor, S. H. Hosseini Nasab, Qiang Zhang, and Colin R. Smith
- Subjects
Tendon strains ,Loading conditions ,Anterior cruciate ligament reconstruction ,medicine.medical_treatment ,Dynamic imaging ,Biomedical Engineering ,Strain (injury) ,Review ,Tendons ,03 medical and health sciences ,0302 clinical medicine ,Tendon Injuries ,In vivo ,Soft tissue function ,In vivo measurement ,medicine ,Animals ,Humans ,Ligament strains ,Biosensors ,Stretchable sensors ,Ultrasonography ,030222 orthopedics ,Ligaments ,business.industry ,Ultrasound ,Soft tissue ,030229 sport sciences ,medicine.disease ,Biomechanical Phenomena ,Tendon strain ,medicine.anatomical_structure ,Ligament ,business ,Biomedical engineering - Abstract
The critical clinical and scientific insights achieved through knowledge of in vivo musculoskeletal soft tissue strains has motivated the development of relevant measurement techniques. This review provides a comprehensive summary of the key findings, limitations, and clinical impacts of these techniques to quantify musculoskeletal soft tissue strains during dynamic movements. Current technologies generally leverage three techniques to quantify in vivo strain patterns, including implantable strain sensors, virtual fibre elongation, and ultrasound. (1) Implantable strain sensors enable direct measurements of tissue strains with high accuracy and minimal artefact, but are highly invasive and current designs are not clinically viable. (2) The virtual fibre elongation method tracks the relative displacement of tissue attachments to measure strains in both deep and superficial tissues. However, the associated imaging techniques often require exposure to radiation, limit the activities that can be performed, and only quantify bone-to-bone tissue strains. (3) Ultrasound methods enable safe and non-invasive imaging of soft tissue deformation. However, ultrasound can only image superficial tissues, and measurements are confounded by out-of-plane tissue motion. Finally, all in vivo strain measurement methods are limited in their ability to establish the slack length of musculoskeletal soft tissue structures. Despite the many challenges and limitations of these measurement techniques, knowledge of in vivo soft tissue strain has led to improved clinical treatments for many musculoskeletal pathologies including anterior cruciate ligament reconstruction, Achilles tendon repair, and total knee replacement. This review provides a comprehensive understanding of these measurement techniques and identifies the key features of in vivo strain measurement that can facilitate innovative personalized sports medicine treatment., Annals of Biomedical Engineering, 49 (1), ISSN:1573-9686, ISSN:0191-5649, ISSN:0090-6964
- Published
- 2020
- Full Text
- View/download PDF
50. Independent and Joint Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer: A Prospective Nested Case–Control Study
- Author
-
Bin Liu, Sanford M. Dawsey, Jin-Hu Fan, Neal D. Freedman, You-Lin Qiao, Philip R. Taylor, Jianfeng Cui, Wen Chen, Liangyu Yin, Christian C. Abnet, Tingyuan Li, and Jian Yin
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Epidemiology ,Hepatitis C virus ,Population ,chemistry.chemical_element ,Calcium ,medicine.disease_cause ,Gastroenterology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Vitamin D and neurology ,Humans ,Prospective Studies ,Vitamin D ,education ,Prospective cohort study ,Hepatitis B virus ,education.field_of_study ,business.industry ,Liver Neoplasms ,Cancer ,Middle Aged ,medicine.disease ,030104 developmental biology ,Oncology ,chemistry ,Case-Control Studies ,030220 oncology & carcinogenesis ,Nested case-control study ,Female ,business - Abstract
Background: Accumulating evidence has shown that serum calcium and vitamin D may be associated with or influence various cancer risks. However, no prospective studies have evaluated the independent and joint associations between prediagnostic levels of serum calcium and vitamin D and future risk of incident primary liver cancer. Methods: We used a nested case–control design to evaluate subjects over 22 years of follow-up. Serum calcium, 25-hydroxy vitamin D [25(OH)D], and three markers of hepatitis B virus and hepatitis C virus were measured in baseline serum from 226 incident primary liver cancer cases and 1,061 matched controls. We calculated ORs and 95% confidence intervals (CI) using logistic regression to estimate the associations between calcium, 25(OH)D, and primary liver cancer risk. Results: Multivariable adjusted models showed that subjects with both low (ORLow/Medium = 1.48, 95% CI = 1.01–2.17) or high (ORHigh/Medium = 1.92, 95% CI = 1.34–2.76) calcium had an increased primary liver cancer risk, while those with high 25(OH)D had a decreased risk of primary liver cancer (ORHigh/Medium = 0.54, 95% CI = 0.35–0.82). In joint analyses, when compared with subjects with medium calcium and 25(OH)D, subjects with high calcium and medium 25(OH)D had elevated odds of developing primary liver cancer (OR = 1.89, 95% CI = 1.17–3.05); those with medium calcium and high 25(OH)D had reduced odds of developing primary liver cancer (OR = 0.34, 95% CI = 0.17–0.67); and subjects in other classifications of calcium and serum 25(OH)D levels had no change in the odds of developing primary liver cancer (all P > 0.05). Conclusions: In a nutrient-deficient population, we found that serum calcium and serum 25(OH)D could potentially be modifiable risk or protective factors. Impact: Our findings provide potential targets for primary liver cancer prevention and control.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.